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In September 2009, the Connecticut Department of Public 
Health (DPH) identified an outbreak of Salmonella gastroen-
teritis among attendees at a reception. A case-control study and 
environmental and laboratory investigations were conducted. 
Nine case-patients and 14 control subjects were identified. 
Potato salad consumption was strongly associated with illness 
(odds ratio [OR] = 84.0). During the investigation, food ser-
vice workers were observed to have bare-handed contact with 
ready-to-eat food. Five case-patients and one asymptomatic 
food service worker had stool samples positive for Salmonella 
species. Two Salmonella serotypes were identified, Salmonella 
enterica serovar Schwarzengrund and Salmonella enterica sero-
var Typhimurium variant O:5–, including coinfection in one 
case-patient and one food service worker. The isolates of each 
respective serotype (S. Schwarzengrund and S. Typhimurium 
variant O:5–) had indistinguishable pulsed-field gel electro-
phoresis (PFGE) patterns. Potato salad was the likely source 
of the outbreak but the contamination mechanism is unclear. 
Control measures included exclusion of the food service worker 
with Salmonella-positive stool from the restaurant until two 
consecutive stool samples yielded no bacterial growth. Standard 
public health laboratory practices in Connecticut and testing 
techniques used specifically during this investigation led to the 
rapid identification of the two serotypes. Multiple-serotype 
Salmonella outbreaks might occur more frequently than rec-
ognized; knowledge of all Salmonella serotypes involved in an 
outbreak might help implicate the outbreak source, define the 
scope of the outbreak, and determine the selection of appropri-
ate control measures. 
On September 18, 2009, a physician notified the DPH 
Epidemiology and Emerging Infections Program of a laboratory-
confirmed Salmonella infection in a person who had attended 
a reception at a banquet hall on September 6. Preliminary 
information indicated that other attendees became symptomatic 
with gastrointestinal illness after the reception. Food served at 
the reception was prepared at an off-site licensed restaurant, 
delivered to the banquet hall by restaurant staff, and set up as 
a self-serve buffet. DPH and the local health department con-
ducted an investigation to determine the source and extent of 
the illnesses and to recommend control measures.
A case-control study was conducted among attendees. A 
case was defined as diarrhea (three or more loose stools during 
a 24-hour period) in a reception attendee within 5 days after 
the reception. A control subject was defined as an attendee who 
did not experience gastrointestinal illness. Because no guest 
list existed, contact information for ill attendees was provided 
by the reception host; control subjects and additional case-
patients were recruited by asking known attendees to identify 
and provide contact information for other attendees. Contact 
information was obtained for 25 (17%) of the approximately 
150 attendees. DPH conducted telephone interviews during 
September 21–25 regarding illness history and food consumed 
at the reception; an itemized list of foods served at the recep-
tion was used to obtain food consumption histories. Of the 25 
interviewed attendees, nine (36%) met the case definition, 14 
qualified as control subjects, and two were excluded because 
they reported gastrointestinal illness that did not meet the case 
Multiple-Serotype Salmonella Gastroenteritis Outbreak After a Reception — 
Connecticut, 2009
INSIDE
1098 Use of a Self-Assessment Questionnaire for Food 
Safety Education in the Home Kitchen — Los 
Angeles County, California, 2006–2008
1102 Updated Recommendations for Prevention of 
Invasive Pneumococcal Disease Among Adults 




The MMWR series of publications is published by the Office of Surveillance, Epidemiology, and Laboratory Services, Centers for Disease 
Control and Prevention (CDC), U.S. Department of Health and Human Services, Atlanta, GA 30333.
Suggested citation: Centers for Disease Control and Prevention. [Article title]. MMWR 2010;59:[inclusive page numbers].
Centers for Disease Control and Prevention
Thomas R. Frieden, MD, MPH, Director
Harold W. Jaffe, MD, MA, Associate Director for Science
James W. Stephens, PhD, Office of the Associate Director for Science
Stephen B. Thacker, MD, MSc, Deputy Director for Surveillance, Epidemiology, and Laboratory Services
MMWR Editorial and Production Staff
Christine G. Casey, MD, (Acting) Editor, MMWR Series
Virginia A. Caine, MD, Indianapolis, IN
Jonathan E. Fielding, MD, MPH, MBA, Los Angeles, CA 
David W. Fleming, MD, Seattle, WA
William E. Halperin, MD, DrPH, MPH, Newark, NJ
King K. Holmes, MD, PhD, Seattle, WA
Deborah Holtzman, PhD, Atlanta, GA
John K. Iglehart, Bethesda, MD
Dennis G. Maki, MD, Madison, WI
Sheryl B. Lyss, MD, MPH,  (Acting) Deputy Editor, MMWR Series
Robert A. Gunn, MD, MPH, Associate Editor, MMWR Series
Teresa F. Rutledge, Managing Editor, MMWR Series
Douglas W. Weatherwax, Lead Technical Writer-Editor
Donald G. Meadows, MA, Jude C. Rutledge, Writer-Editors
Martha F. Boyd, Lead Visual Information Specialist
Malbea A. LaPete, Stephen R. Spriggs, Terraye M. Starr  
Visual Information Specialists
Quang M. Doan, MBA, Phyllis H. King  
Information Technology Specialists
Patricia Quinlisk, MD, MPH, Des Moines, IA
Patrick L. Remington, MD, MPH, Madison, WI
Barbara K. Rimer, DrPH, Chapel Hill, NC
John V. Rullan, MD, MPH, San Juan, PR
William Schaffner, MD, Nashville, TN
Anne Schuchat, MD, Atlanta, GA
Dixie E. Snider, MD, MPH, Atlanta, GA
John W. Ward, MD, Atlanta, GA
MMWR Editorial Board
William L. Roper, MD, MPH, Chapel Hill, NC, Chairman
MMWR  Morbidity and Mortality Weekly Report
1094 MMWR  /  September 3, 2010  /  Vol. 59  /  No. 34
definition. Of the nine case-patients, eight (89%) had 
abdominal cramping, seven (78%) had subjective 
fever, six (67%) had muscle aches, and four (44%) 
had bloody stools (Table). Median age was 31 years 
(range: 25–51 years); five (56%) were male. The 
median incubation period* was 13.5 hours (range: 
9.5–95.5 hours); median illness duration was 8.5 days 
(range: 0.5–14 days). A case-control analysis revealed 
that case-patients were significantly more likely than 
control subjects to have consumed potato salad (88% 
versus 8%, respectively; OR = 84.0; 95% confidence 
interval = 3.3–4,077; p<0.001).
During September 21–October 1, the local health 
department and the DPH Food Protection Program 
conducted an environmental investigation of the res-
taurant in which the food served at the reception had 
been prepared. Of the four persons who worked at the 
restaurant, two were directly involved in food prepara-
tion for the reception. All four were interviewed, and 
none reported experiencing gastrointestinal illness. 
During the investigation, food service workers were 
observed to have bare-handed contact with ready-to-
eat food and did not practice adequate hand washing. 
Preparation procedures of items served at the recep-
tion, including the potato salad, were reviewed, and 
environmental samples of food contact surfaces and 
spices used in preparation of the reception food were 
collected for testing. The environmental and spice 
samples were obtained >3 weeks after the outbreak 
occurred and after the facility had been cleaned; 
Salmonella was not detected in these samples. No 
leftover potato salad was available for testing. 
The stool sample from the index case-patient 
was collected on September 14 and processed at 
a private laboratory; the clinical isolate was then 
sent to the DPH laboratory for confirmation. Stool 
specimens from five additional case-patients and 
all four food service workers were collected during 
September 21–October 7 and tested at the DPH 
laboratory. The specimens were first plated to selec-
tive media to test for the presence of Salmonella, 
Shigella, Campylobacter, and Escherichia coli O157. 
After incubation, presumptive Salmonella colonies 
* Meal service began at approximately 6 p.m. The incubation period 
was calculated using 7:30 p.m. as the likely time by which all case-
patients had eaten food.
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were serotyped† and subtyped genetically by PFGE. 
Serotyping and PFGE testing were not sequential.§ 
The isolate from the index case-patient was 
serotyped as S. Typhimurium variant O:5–. Initial 
serotyping steps performed on Salmonella iso-
lates obtained from stool specimens revealed a 
preliminary antigen result consistent with the 
S. Typhimurium variant O:5– already identified 
for the index case-patient. Consequently, inves-
tigators assumed that S. Typhimurium variant 
O:5– was the only outbreak serotype. Next, while 
final serotyping was pending, Salmonella isolates 
were submitted for PFGE. Testing of the first five 
isolates yielded two distinct PFGE patterns (PFGE 
XbaI patterns JPXX01.0456 and JM6X01.0036¶). 
One PFGE pattern appeared to be consistent with 
S. Typhimurium; the other appeared to be consistent 
with S. Schwarzengrund. The results of serotyping 
verified the presence of both S. Typhimurium variant 
O:5– and S. Schwarzengrund. 
The identification of both S. Typhimurium variant 
O:5– and S. Schwarzengrund in reception attendees 
raised the possibility that two different Salmonella 
serotypes might be involved in the outbreak. 
Therefore, laboratory staff systematically collected 
multiple single-colony picks from original media to 
screen for the presence of an additional Salmonella 
serotype. After all testing was complete, including 
isolation, serotyping, and PFGE, two of the six case-
patients with specimens at the DPH laboratory were 
determined to be infected with S. Typhimurium 
variant O:5–, another two with S. Schwarzengrund, 
and one with both; no pathogens were isolated from 
the stool specimen of the sixth case-patient. A seventh 
case-patient’s stool specimen was tested at a private 
laboratory; no Salmonella was detected. Of the four 
food service worker specimens tested, one yielded 
both S. Schwarzengrund and S. Typhimurium variant 
O:5– and the other three were negative. All respec-
tive S. Schwarzengrund isolates and S. Typhimurium 
variant O:5– isolates had indistinguishable PFGE 
patterns. 
TABLE. Demographic and clinical characteristics of Salmonella gastroenteritis outbreak case-patients* at a reception — Connecticut, 2009
Characteristic
Case-patient
1 2 3† 4 5 6 7 8 9
Age (yrs) 25 51 27 31 N/A§ N/A 31 34 34
Incubation (hrs)¶ 9.5 11.5 12.5 12.5 13.5 24.5 40.5 64.5 95.5
Signs and symptoms
Diarrhea** Yes Yes Yes Yes Yes Yes Yes Yes Yes
Abdominal 
cramping
Yes Yes Yes Yes Yes Yes Yes No Yes
Fever (subjective) Yes No Yes Yes Yes Yes Yes No Yes
Muscle aches No Yes Yes Yes N/A Yes Yes No Yes
Bloody stools No No Yes Yes No Yes Yes No No
Duration of illness 14 days 7 days 10 days 10 days 2 days 14 days 5 days <1 day N/A
Pathogen†† Salmonella 
Schwarzengrund















Not tested Negative 
at private 
laboratory
 * Does not include food service workers; stool specimen from one food service worker tested positive for Salmonella enterica serovar Typhimurium variant O:5- and 
Salmonella Schwarzengrund at the Connecticut Department of Public Health (DPH) laboratory.
 † Index case-patient; clinical isolate, but not stool specimen, was available for testing.
 § N/A = information not available.
 ¶ Meal service began at approximately 6 p.m. Incubation period calculated using 7:30 p.m. as the likely time by which all case-patients had eaten food. 
 ** Three or more loose stools during a 24-hour period in a reception attendee within 5 days after the reception.
 †† Pathogens were identified by Connecticut DPH laboratory by serotyping and pulsed-field gel electrophoresis.
† Salmonella serotypes are based on the immunoreactivity of two 
surface structures, the O antigen and the H antigen. Serotyping was 
performed according to the Kauffmann-White Scheme. Additional 
information available at http://www.cdc.gov/ncidod/dbmd/
phlisdata/salmtab/2006/salmonellaannualsummary2006.pdf.
§ Salmonella isolates were first screened for O antigens by using the 
slide agglutination method, a process that usually takes <1 minute to 
perform. Screening for H antigens was done by a tube agglutination 
test, a process that can take days to complete. While the H antigen 
test was pending, a fresh culture generated from a single-colony pick 
from the selective media underwent PFGE testing; single-colony 
picks from different persons’ samples were run on the same PFGE 
gel. Because H antigen and PFGE testing ran concurrently, the 
PFGE results were typically available before H antigen testing was 
complete, and therefore, before the final serotype was known.
¶ PFGE pattern names were assigned by CDC’s PulseNet database.
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On September 25, the food service worker with 
positive stool findings was reinterviewed and reaf-
firmed the absence of recent gastrointestinal illness, 
including around the time of the reception. This food 
service worker had been responsible for transporting 
food to the banquet hall and ensuring that the food 
was maintained at the correct temperature before 
serving, but reported not having prepared, consumed, 
nor served any of the food.
Control measures implemented by the local health 
department included exclusion of the Salmonella-
positive food service worker from the restaurant for 
approximately 2 weeks until two consecutive stool 
cultures obtained ≥24 hours apart had no bacterial 
growth. Health department staff members provided 
information about employee health policies and 
employee hygiene to the restaurant owners and 
reviewed the information with them.
Reported by 
L Mank, MS, M Mandour, Connecticut Dept of 
Public Health Laboratory; T Rabatsky-Ehr, MPH, 
Q Phan, MPH, J Krasnitski, MPH, J Brockmeyer, 
MPH, L Bushnell, C Applewhite, M Cartter, MD, 
Connecticut Dept of Public Health. J Kattan, MD, EIS 
Officer, CDC.
Editorial Note 
Epidemiologic and laboratory data demonstrate 
that an outbreak of Salmonella infection with two dif-
ferent serotypes occurred among guests who attended a 
reception; potato salad was the likely source of this out-
break, but the contamination mechanism is unclear. 
Likewise, whether the food service worker might have 
unknowingly contaminated a food item or whether the 
food service worker also was infected through the same 
source as the case-patients remains unclear. 
Salmonella is the most common bacterial cause 
of foodborne disease outbreaks in the United States 
(1). However, outbreaks of Salmonella infection with 
multiple serotypes are reported less commonly in the 
literature (2–4). Standard public health laboratory 
practices in Connecticut,** as well as testing tech-
niques used specifically in the context of this outbreak 
investigation, led to the rapid identification of two 
distinct serotypes. Connecticut requires all identi-
fied Salmonella isolates to be submitted to the DPH 
laboratory, where serotyping and PFGE are routinely 
performed; private laboratories in Connecticut do 
not have the capacity to perform full serotyping and 
PFGE testing. Initiating PFGE testing before finaliza-
tion of serotyping led to more rapid recognition of the 
two different serotypes; complete serotyping can take 
days, whereas PFGE testing can take as little as 1 day 
after pure isolate is available for analysis. 
Systematically screening and testing multiple 
single-colony picks on each original culture plate, 
a time-intensive practice that is usually not part of 
routine laboratory protocol, facilitated identifying 
both outbreak serotypes. This approach particularly 
aided discovery of coinfection with two Salmonella 
serotypes in one case-patient and the food service 
worker. The recognition of coinfection helped inves-
tigators conclude that a multiple-serotype outbreak 
had occurred. Furthermore, testing multiple colonies 
is dependent upon availability of stool specimens; 
had all of the case-patients’ stool been first tested 
at a private laboratory, such that only single clini-
cal isolates were available for testing at the DPH 
What is already known on this topic?
Salmonella commonly causes foodborne illness; 
however, Salmonella outbreaks involving multiple 
serotypes are reported less commonly.
What does this report add?
Epidemiologic and laboratory data demonstrate that 
an outbreak of Salmonella infection with two different 
serotypes occurred among guests who attended 
a reception; rapid identification of the multiple 
serotypes was facilitated by confirmatory testing 
at the state laboratory, specifically the use of stool 
samples for subsequent serotyping and pulsed-field 
gel electrophoreses testing. 
What are the implications for public health practice?
Multiple-serotype Salmonella outbreaks might occur 
more frequently than recognized; if resources permit, 
health departments can better characterize the 
epidemiology of Salmonella outbreaks by performing 
serotyping and PFGE, and by testing multiple single-
colony picks when multiple Salmonella serotypes are 
suspected.
 ** Connecticut is a participant in the Foodborne Diseases Active 
Surveillance Network (FoodNet), the principle foodborne 
disease component of CDC’s Emerging Infections Program 
(EIP). FoodNet is a collaborative project between CDC, 10 EIP 
sites, the U.S. Department of Agriculture, and the Food and Drug 
Administration. As part of FoodNet, Connecticut conducts active, 
laboratory-based surveillance of foodborne bacterial and parasitic 
pathogens. Additional information is available at http://www.cdc.
gov/foodnet.
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laboratory, coinfection in the case-patient would not 
have been discovered. 
Not all states require that all Salmonella isolates 
be submitted to the public health laboratory for 
serotyping and PFGE. Additionally, in an outbreak 
setting, some states with resource limitations might 
only perform comprehensive testing on a very limited 
number of case-patient specimens. If the outbreak 
described in this report had taken place in a state 
without a requirement for submission of Salmonella 
isolates to the public health laboratory or in a state 
in which the number of specimens tested was strictly 
limited, the discovery of both Salmonella serotypes 
might not have occurred. In those public health labo-
ratories that perform both serotype and PFGE testing, 
but do not do so simultaneously, multiple-serotype 
infections would not be identified as quickly as they 
were in this outbreak. 
Although not specifically illustrated by the find-
ings in this report, not knowing about all Salmonella 
serotypes involved in an outbreak might hinder the 
epidemiologic investigation and the public health 
response. Certain Salmonella serotypes are known 
to be likely associated with particular food types or 
animal sources. Consequently, knowledge of multiple 
serotypes involved in an outbreak can help focus 
the investigation on potential outbreak sources. 
Databases, such as PulseNet,†† can identify and link 
infected persons to a particular outbreak, thereby 
defining the scope. In a recent outbreak, PulseNet 
matched two different Salmonella serotypes to an 
outbreak linked to peppers used in making salami (4). 
If an outbreak were detected through PulseNet, not 
knowing all involved serotypes might result in cases 
not being associated with the outbreak. If only cases 
with a single serotype were included in such responses, 
sampled cases might not be representative of all cases. 
Furthermore, identifying a greater number of cases 
associated with multiple serotypes in an outbreak 
might increase the statistical power of the study to 
implicate a food vehicle or other outbreak source 
through epidemiologic analysis. Implementation of 
appropriate control measures relies on knowing the 
implicated source and the scope of the outbreak, 
particularly if multiple serotypes are involved.
The findings in this report are subject to at least 
three limitations. First, lack of a comprehensive guest 
list prohibited a cohort analysis. Second, recruitment 
of control subjects through known attendees might 
have introduced selection bias; attendees who knew 
each other might have had similar food preferences, 
potentially increasing the likelihood that case-patient 
and control subject food histories were similar. 
However, such a tendency would bias the results 
toward showing no association. Finally, the time lag 
between the reception and collection of environmen-
tal samples limited their usefulness.
Multiple-serotype Salmonella outbreaks might 
occur more frequently than recognized. Health depart-
ments should be aware of the possible occurrence of 
such outbreaks to better characterize their epidemiol-
ogy. This outbreak demonstrates the importance of 
capacity to perform Salmonella serotyping and PFGE 
testing at public health laboratories. In outbreak 
settings, obtaining stool samples and performing 
comprehensive serotyping and PFGE at public health 
laboratories facilitate detection of multiple Salmonella 
serotypes. When more than one Salmonella serotype 
is suspected in an outbreak, screening and testing 
multiple single-colony picks could be considered, 
if resources permit, as an important technique for 
identifying multiple serotypes, including coinfection, 
among cases.
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Foodborne diseases remain an important cause 
of morbidity in the United States among all age 
groups (1,2). A potentially important contributor 
to this morbidity is improper food handling and 
preparation practices in kitchens at restaurants and 
in private homes (1,2). In 1998, the Los Angeles 
County Department of Public Health (LACDPH) 
established numeric scores for restaurant inspections 
and posted grades for these inspections publicly; 
by the end of 1998 this initiative was credited with 
helping to reduce by 13.1% (compared with 1997) 
the number of hospitalizations for foodborne infec-
tions from nontyphoidal Salmonella, Campylobacter, 
and Escherichia coli in the region (3). In the spring 
of 2006, the LACDPH Environmental Health 
Program launched the Home Kitchen Self-Inspection 
Program, a voluntary self-inspection and education 
program, to promote safer food hygiene practices at 
home. This report describes the implementation of 
this program and the results from its web-based self-
assessment questionnaire, the Food Safety Quiz, for 
the initial program period of 2006–2008. Overall, 
approximately 13,000 adults completed the quiz; 34% 
received an A rating, 27% a B, 25% a C, and 14% 
received a numeric score because they scored lower 
than 70% on the self-assessment. Use of interactive, 
online learning tools such as the Food Safety Quiz 
can be used to promote home food safety in the com-
munity. Further research is needed to evaluate and 
improve the program content and to assess its effect 
on changing food handling and preparation practices 
in the home kitchen. 
The Home Kitchen Self-Inspection Program 
includes a Food Safety Quiz* that is based on emerg-
ing evidence that the use of online, interactive learn-
ing tools are conducive to problem-based learning, 
improve self-efficacy and self-mastery of selected 
skills, and offer convenience and flexibility to the 
learner (4). The content of the questions was guided 
by food safety education principles† from the U.S. 
Department of Agriculture: clean, separate, cook, 
and chill. The framework of the quiz was based on 
adult learning theories (4) and emphasized such food 
handling practices as the need to clean and sanitize 
cutting boards after handling poultry, the safe han-
dling of raw eggs, and appropriate methods for the 
refrigeration of cooked and uncooked foods. The quiz 
provided valuable instruction to respondents about 
better ways to maintain home food safety.
The quiz, available only in English, queried 
respondents regarding food handling and preparation 
practices at home, assigning a letter grade at comple-
tion using a scoring algorithm (i.e., A [90%–100%], 
B [80%–89%], C [70%–79%], or an actual score if 
the rating was below 70%) that was adapted from, 
but not identical to, the algorithm used for restau-
rant grading. Although quiz questions were based 
on food hygiene standards used routinely to evaluate 
food safety in full-service restaurants, the question-
naire limited queries about physical structure (e.g., 
damaged floor tiles and cracked walls) and excluded 
questions on the food handler certification require-
ments; instead, the quiz rating algorithm specifically 
focused on food hygiene practices that are considered 
by the LACDPH Environmental Health Program to 
be the most relevant to home kitchens and focused 
on cleaning and chilling as two areas of food safety 
that county residents might often overlook when 
cooking at home. 
The quiz included 57 questions; 45 were formatted 
as equally weighted yes/no questions, simulating an 
inspection checklist that could be completed within 
10 minutes. The remaining 12 questions inquired 
about demographic information. To receive the final 
score/self-inspection rating, all questions had to be 
completed. Respondents who received an A rating 
were mailed a placard with this grade as recogni-
tion for their good food handling practices. During 
March–May, the first 3 months after launch, the quiz 
was marketed to the public using printed materials 
and public service announcements in the local media, 
including television and radio, and at public events.
Use of a Self-Assessment Questionnaire for Food Safety Education 
in the Home Kitchen — Los Angeles County, California, 2006–2008
* Available at http://publichealth.lacounty.gov/phcommon/public/
eh/fsquiz.
† Available at http://www.fsis.usda.gov/be_foodsafe/bfs_messages/
index.asp.
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During 2006–2008, a total of 27,129 visits to the 
website were recorded; 19,205 (71%) respondents 
reported Los Angeles County postal codes,§ for which 
13,274 unique respondents completed the quiz. Most 
respondents were female (68%), ranged in age from 
18 to 59 years (78%), spoke English at home (86%), 
and reported being the primary cook (81%); 17% of 
respondents believed that they had ever become ill 
from eating at home (Table 1).
When queried regarding food handling and prepa-
ration practices, approximately 27% reported not 
storing partially cooked foods that would not be used 
immediately in the refrigerator before final cooking, 
28% said they did not remove all jewelry from hands 
and/or did not keep fingernails trimmed when cook-
ing, and 26% reported that their kitchen shelves and 
cabinets were not clean and free from dust (Table 2). 
Approximately 36% of respondents said that they did 
not have a properly working thermometer inside the 
refrigerator. Approximately 9% reported that they had 
flies inside the home; 6% reported cockroaches; and 
5% reported rodents inside their homes. 
If home kitchens were graded similarly to res-
taurants and were required to post letter grades in 
the kitchen based on results from the quiz, 34% of 
respondents would have received an A rating, 27% 
a B, 25% a C; 14% would have received a numeric 
score because they scored lower than 70%.
Reported by
T Kuo, MD, H Dela Cruz, MS, M Redelings, MPH, 
LV Smith, DrPH, R Reporter, MD, PA Simon, MD, 
JE Fielding, MD, SM Teutsch, MD, Los Angeles County 
Dept of Public Health, Los Angeles, California.
Editorial Note 
Home kitchen-related foodborne diseases are 
vastly underreported (1,2). The findings in this report 
show that even among interested and motivated per-
sons, food handling and preparation deficiencies occur 
frequently in the home setting. Only approximately 
one third of respondents completing the quiz would 
have received an A rating. 
Although the percentages of home kitchens 
assigned A or B ratings (61%) was considerably lower 
than for full-service restaurants (98%) during 2006–
2008 (LACDPH, unpublished data, 2009), these 
observations would not be directly comparable to 
restaurants because the self-assessment and grading of 
home kitchens were exclusively based on respondent 
self-reports and were intended to promote learning. 
Restaurants, by contrast, were physically inspected by 
TABLE 1. Characteristics of respondents (N = 13,274) to 
the Home Kitchen Self-Inspection Program Food Safety 






 <18 127 (1)
 18–39 4,846 (37)
 40–59 5,420 (41)
 ≥60 1,149 (9)
 Not reported 1,732 (13)






Primary cook at home 10,747 (81)
Restaurant ratings influenced decisions to 
eat at restaurants
11,804 (89)
Respondent believed he/she had become 
ill from eating at home
2,259 (17)
Ever reported a foodborne illness 1,511 (11)
* Percentages might not sum to 100 because of rounding.
† Not mutually exclusive; respondents could list more than one 
response.
§ Duplicates (i.e., persons who attempted the online self-assessment 
more than once) were identified through an algorithm and 
eliminated. The algorithm accounted for consistency among postal 
code, date when quiz was taken, and demographic information. 
What is already known on this topic?
In 1998, the Los Angeles County Department of Public 
Health launched an initiative that publicly posted 
newly implemented restaurant grades; that year, 
the initiative was credited with helping to reduce by 
13.1% (compared with 1997) the number of hospital-
izations for foodborne infections from nontyphoidal 
Salmonella, Campylobacter, and Escherichia coli in the 
region.
What is added by this report?
According to a new self-assessment food safety quiz 
that graded home kitchens similarly to restaurants, 
34% of respondent’s home kitchens would have 
received an A rating, 27% a B, 25% a C, and 14% 
would have received a numeric score because they 
scored lower than 70% on the self-assessment. 
What are the implications for public health practice?
Innovative tools that educate the public about home 
kitchen safety can complement established restaurant 
hygiene rating programs and aid other prevention 
efforts to further reduce foodborne illnesses.
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trained food safety professionals and were required to 
have at least one certified food handler on staff. 
During 1999–2007, foodborne diseases caused a 
reported 2,590 hospitalizations and 17 deaths in Los 
Angeles County; approximately 600 hospitalizations 
occurred in 2007 (5–7). These numbers are considered 
underestimates because not all foodborne illnesses 
leading to hospitalization or death are confirmed by 
laboratory testing (8). In 2006, the most common 
locations for reported foodborne outbreaks in Los 
Angeles County were restaurants (16 [43%]), followed 
by foods that were brought or catered to a work place 
(five [14%]) or eaten at home (five [14%]) (6). The 
initial decline in hospitalizations related to foodborne 
illnesses after the public posting of restaurant grades 
in Los Angeles County in 1998 (3) stalled after 2002 
(5). This pattern suggests that addressing other sources 
of infection (e.g., the food supply, hazards in the food 
processing and distribution chain, the workplace, and 
in particular, the home kitchen) might be important 
to further reduce foodborne illness (6,8). The Home 
Kitchen Self-Inspection Program was developed by 
the LACDPH to further help address this public 
health problem.
The findings in this report are subject to at least 
two limitations. First, although approximately 13,000 
respondents completed the quiz, the sample of respon-
dents is unlikely to be representative of all county 
residents for several reasons. Because the questionnaire 
was available only in English, non-English speak-
ing ethnic minorities could not have participated. 
Respondents enrolled in this self-assessment exercise 
based on their interest in food safety. Only persons 
with computers and access to the Internet were able 
to participate in the program. Second, the relationship 
between these practices and conditions and actual 
home kitchen conditions remains unknown.
The Home Kitchen Self-Inspection Program is 
the largest effort to date to use a web-based, self-
assessment questionnaire as a population learning 
tool to provide feedback and education about home 
kitchen safety. LACDPH is applying the information 
gleaned from the quiz (e.g., implementation barriers, 
responses about home kitchen practices, and program 
data biases) to explore ways to improve the program, 
including 1) increasing the specificity of the question 
items so that they are more relevant to the home 
kitchen environment, 2) further tailoring the quiz to 
ethnically diverse or harder-to-reach communities, 
and 3) conducting a program evaluation to validate 
the program’s benefits to consumer learning and food 
handling practices at home. Innovative tools that 
educate the public about home kitchen safety can 
complement established restaurant hygiene rating 
programs and aid other prevention efforts to further 
reduce foodborne illnesses.
TABLE 2. Number and percentage of respondents (N = 13,274) reporting unsafe kitchen practices,* by sex — Home Kitchen Self-Inspection 
Program Food Safety Quiz, Los Angeles County, California, 2006–2008
Home kitchen practice
Males Females Total
No. (%) No. (%) No. (%)
When cooking big portions of food to serve later, respondent did not rapidly cool and 
store it in refrigerator
2,652 (62) 5,815 (65) 8,467 (64)
Respondent did not have a properly working thermometer inside refrigerator 1,653 (39) 3,054 (34) 4,707 (36)
Respondent did not store raw meats below all other food in refrigerator† 1,393 (33) 2,865 (33) 4,258 (33)
Respondent did not remove all jewelry from hands before preparing food and/or did 
not keep fingernails trimmed
925 (22) 2,739 (31) 3,664 (28)
Respondent did not store partially cooked foods that would not be used immediately 
in refrigerator before final cooking
1,141 (27) 2,465 (27) 3,606 (27)
Kitchen shelves and cabinets were not clean and free from dust 1,028 (24) 2,391 (27) 3,419 (26)
Food in refrigerator was not well-spaced so that cool air can circulate freely 949 (22) 2,055 (23) 3,004 (23)
Flies inside the home 468 (11) 732 (8) 1,200 (9)
Cockroaches inside the home 314 (7) 522 (6) 836 (6)
Rodents inside the home (not including pet rodents in cages) 277 (7) 414 (5) 691 (5)
* As determined by the Los Angeles County Department of Public Health, based on the California Health and Safety Code (available at http://www.publichealth.
lacounty.gov/eh/docs/specialized/cacode.pdf).
† Denominator used to derive the percentage is 12,932, which excludes the 342 respondents who reported that they did not prepare raw meats in their home.
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Invasive disease from Streptococcus pneumoniae 
(pneumococcus) is a major cause of illness and death 
in the United States, with an estimated 43,500 cases 
and 5,000 deaths among persons of all ages in 2009 
(1). This report provides updated recommendations 
from the Advisory Committee on Immunization 
Practices (ACIP) for prevention of invasive pneumo-
coccal disease (IPD) (i.e., bacteremia, meningitis, or 
infection of other normally sterile sites [2]) through 
use of the 23-valent pneumococcal polysaccharide 
vaccine (PPSV23) among all adults aged ≥65 years 
and those adults aged 19–64 years with underlying 
medical conditions that put them at greater risk for 
serious pneumococcal infection. The new recom-
mendations include the following changes from 1997 
ACIP recommendations (2): 1) the indications for 
which PPSV23 vaccination is recommended now 
include smoking and asthma, and 2) routine use of 
PPSV23 is no longer recommended for Alaska Natives 
or American Indians aged <65 years unless they have 
medical or other indications for PPSV23. ACIP rec-
ommendations for revaccination with PPSV23 among 
the adult patient groups at greatest risk for IPD (i.e., 
persons with functional or anatomic asplenia and 
persons with immunocompromising conditions) 
remain unchanged (2). ACIP recommendations for 
prevention of pneumococcal disease among infants 
and youths aged ≤18 years using the 13-valent pneu-
mococcal conjugate vaccine (PCV13) and PPSV23 
are published separately (3).
Changes in IPD Incidence
Indirect vaccine effects (i.e., herd effects) have 
reduced pneumococcal infections among unvacci-
nated persons of all ages, including those aged ≥65 
years, since introduction of the routine infant 7-valent 
pneumococcal conjugate vaccine (PCV7) immuniza-
tion program in 2000 (4). Data from Active Bacterial 
Core surveillance (ABCs)* indicate that, by 2007, 
the overall incidence rate of IPD among persons of 
all ages had decreased by 45% (from 24.4. to 13.5 
per 100,000 population), compared with 1998–1999 
before PCV7 was introduced (4). Among persons 
aged 18–49 years, 50–64 years, and ≥65 years, rates 
of IPD decreased 40%, 18%, and 37%, respectively. 
The decreases resulted from reductions of 87% to 
92% in cases of infection with serotypes covered 
in PCV7 (4). Despite the major direct and indirect 
PCV7 effects, IPD remains an important cause of ill-
ness and death. An estimated 43,500 cases and 5,000 
deaths occurred among persons of all ages in 2009; 
approximately 84% of IPD cases and nearly all deaths 
occurred in adults (1). 
Additional indirect effects can be expected to occur 
when the PCV13 immunization program, initiated in 
2010, is fully implemented, although the magnitude 
of these effects is difficult to predict (3). In 2008, the 
serotypes covered in PCV13 caused 53%, 49%, and 
44% of IPD cases among persons aged 18–49 years, 
50–64 years, and ≥65 years, respectively; serotypes 
covered in PPSV23 caused 78%, 76%, and 66% 
of IPD cases among persons in these age groups 
(Figure).
Risk Factors for IPD Among Adults
Rates of pneumococcal infection in the United 
States vary among demographic groups, with higher 
rates among infants, young children, and older per-
sons. The presence of certain underlying medical 
conditions increases the risk for pneumococcal disease 
and its complications (2). The risk for IPD is great-
est among persons who have congenital or acquired 
immunodeficiency, abnormal innate immune 
response, human immunodeficiency virus (HIV) 
infection, or functional or anatomic asplenia (e.g., 
sickle cell disease or congenital or surgical asplenia) 
(Table). Alaska Native children and children among 
certain American Indian populations also have higher 
rates of IPD. Among Alaska Native and American 
Indian adults, the majority of IPD cases occur in per-
sons with underlying medical conditions or other risk 
factors (e.g., heavy alcohol use or smoking) that are 
associated with increased risk for IPD in the general 
population (5).
Updated Recommendations for Prevention of Invasive 
Pneumococcal Disease Among Adults Using the 23-Valent 
Pneumococcal Polysaccharide Vaccine (PPSV23)
* Additional information available at http://www.cdc.gov/abcs/index.
html.
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From 1998–1999 to 2006–2007, the percentage 
of adult IPD patients with underlying medical condi-
tions increased from 52% to 59% among those aged 
18–64 years and from 69% to 81% among those 
aged ≥65 years. This trend suggests that adults with 
high-risk conditions might not have benefited as 
much from the indirect protective effects of childhood 
PCV7 immunization as persons who are relatively 
healthy (4).
Asthma. An estimated 7.3% of U.S. adults have 
active asthma.† A case-control study conducted in 
Tennessee, which identified cases through active, 
population-based and laboratory-based surveillance 
and verified history of asthma from the Tennessee 
Medicaid database, showed that among adults aged 
18–49 years, IPD was more common among persons 
with asthma than persons without asthma (adjusted 
odds ratio [AOR] = 2.4; 95% confidence interval 
[CI] = 1.8–3.3). Among persons with high-risk 
asthma,§ the risk for IPD was nearly twice that for 
persons with low-risk asthma (6). In contrast, in a 
study conducted among a cohort of older veterans 
(average age: 53 years), persons with asthma did not 
have higher rates of hospitalization for pneumococ-
cal pneumonia compared with persons in a group 
without asthma or chronic obstructive pulmonary 
disease (COPD) who were matched to the asthma 
patients by age, sex, and region (7). However, in the 
same study, hospitalization rates for pneumococcal 
pneumonia among persons with COPD were higher 
compared with persons in the control group. Because 
distinguishing between COPD and asthma becomes 
more difficult with advancing age, misclassification 
of persons in this study is a possibility. 
Cigarette smoking. Population-based surveil-
lance studies conducted before introduction of PCV7 
consistently reported that smokers accounted for 
approximately half of otherwise healthy adults with 
IPD (8). During 2001–2003, 53% of IPD patients 
aged 18–64 years were current cigarette smokers 
(CDC, ABCs unpublished data). In a multicenter, 
population-based, case-control study in which IPD 
patients were identified through ABCs, the risk for 
IPD among immunocompetent cigarette smokers 
aged 18–64 years was four times the risk for controls 
who had never smoked (AOR = 4.1; CI = 2.4–7.3) 
(9). Significant dose-response relationships with risk 
for IPD also were observed for number of cigarettes 
smoked and pack-years of smoking (9). Subsequent 
studies confirmed that smoking also increases the risk 
for IPD among other groups, including immunocom-
promised persons (10). 
PPSV23 Efficacy and Effectiveness
Evaluations of PPSV23 efficacy and effectiveness 
among persons in recommended target groups have 
yielded contradictory conclusions for prevention of 
nonbacteremic pneumococcal pneumonia; however, 
most study results are consistent with protection 
against IPD among generally healthy young adults 
and among the general population of older persons. 
Observational studies have suggested effectiveness 
estimates ranging from approximately 50% to 80% 
for prevention of IPD among immunocompetent 
older adults and adults with various underlying ill-
nesses, supporting the recommendations for using 
PPSV23 to prevent IPD (11). However, effectiveness 
has not been demonstrated among immunocompro-
mised persons or very old persons. A recent meta-
analysis of 15 randomized controlled trials (RCTs) 
and seven nonrandomized observational studies of 
PPSV23 efficacy and effectiveness suggested an overall 
efficacy of 74% against IPD (CI = 56%–85%), based 
on pooled results of 10 of the RCTs (12). Analysis 
Abbreviations: PCV7 = 7-valent pneumococcal conjugate vaccine. PCV13  = 13-valent pneu-
mococcal conjugate vaccine. PPSV23 = 23-valent pneumococcal polysaccharide vaccine.
FIGURE. Percentage of invasive pneumococcal disease cases caused by sero-
types covered in three different pneumococcal vaccine formulations  (PCV7, 
PCV13, and PCV23) among adults aged ≥18 years, by age group — Active 






















† Additional information available at http://www.cdc.gov/asthma/
nhis/07/data.htm.
§ Defined as persons with asthma that required at least one of the 
following: 1) admission for asthma to a hospital or visit to an 
emergency department; 2) receipt of a prescription for a course of 
corticosteroids as rescue therapy or a long-term course (120 days 
or more) of oral corticosteroids; or 3) three or more prescriptions 
for β-agonists in the year preceding enrollment in the study.
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of the results from the seven observational studies 
yielded a pooled vaccine effectiveness estimate of 52% 
(CI = 39%–63%). In contrast, a recent meta-analysis 
that included six RCTs estimated the combined 
PPSV23 efficacy against pneumococcal bacteremia 
at only 10%, with a very wide CI (CI = -77%–54%) 
(13). The large difference in findings from these two 
meta-analyses might be related to inclusion of dif-
ferent trials.
Recommendations for Use of PPSV23
At its June and October 2008 meetings, ACIP 
approved new and revised recommendations for the 
use of PPSV23 to prevent IPD among adults aged <65 
years. ACIP concluded that asthma is an independent 
risk factor for IPD and should be included in the 
group of chronic pulmonary diseases (e.g., COPD and 
emphysema) that are indications for PPSV23 (Table); 
thus, ACIP recommended that persons aged 19–64 
years who have asthma should receive a single dose of 
PPSV23 (Box). ACIP also concluded that adults who 
smoke cigarettes are at significantly increased risk for 
IPD and recommended that persons aged 19–64 years 
who smoke cigarettes should receive a single dose of 
PPSV23 and smoking cessation guidance (Box). 
ACIP also revised its recommendation for use 
of PPSV23 among American Indians and Alaska 
Natives. Routine use of PPSV23 is no longer rec-
ommended for persons aged <65 years in these 
populations unless they have a medical condition or 
other indication for PPSV23. However, in certain 
situations, public health authorities may recommend 
PPSV23 for Alaska Natives and American Indians 
aged 50–64 years who are living in areas where the 
risk for IPD is increased.
All persons should be vaccinated with PPSV23 at 
age 65 years. Those who received PPSV23 before age 
65 years for any indication should receive another 
dose of the vaccine at age 65 years or later if at least 
5 years have passed since their previous dose. Those 
who receive PPSV23 at or after age 65 years should 
receive only a single dose. 
Revaccination. ACIP recommendations for 
revaccination remain unchanged from the 1997 
TABLE. Underlying medical conditions or other indications for administration of 23-valent pneumococcal polysaccha-
ride vaccine (PPSV23) among adults aged 19–64 years, by risk group — Advisory Committee on Immunization Practices, 
(ACIP) 2010
Risk group Underlying medical condition or other indication






Chronic liver disease, including cirrhosis 
Cigarette smoking
Persons with functional or anatomic 
asplenia§
Sickle cell disease and other hemoglobinopathies 
Congenital or acquired asplenia, splenic dysfunction, or splenectomy








Diseases requiring treatment with immunosuppressive drugs, including long-term systemic 
corticosteroids or radiation therapy
Solid organ transplantation
Multiple myeloma
* Including congestive heart failure and cardiomyopathies.
† Including chronic obstructive pulmonary disease, emphysema, and asthma.
§ A second dose of PPSV23 is recommended 5 years after the first dose for persons with functional or anatomic asplenia and for immuno-
compromised persons.
¶ Includes B- (humoral) or T-lymphocyte deficiency, complement deficiencies (particularly C1, C2, C3, and C4 deficiencies), and phagocytic 
disorders (excluding chronic granulomatous disease).
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recommendations (2). For most persons for whom 
PPSV23 is indicated, ACIP does not recommend 
routine revaccination. A second dose of PPSV23 is 
recommended 5 years after the first dose for persons 
aged 19–64 years with functional or anatomic asplenia 
and for persons with immunocompromising condi-
tions (Table). ACIP does not recommend multiple 
revaccinations because of insufficient data regarding 
BOX. Updated recommendations for administration of 
23-valent pneumococcal polysaccharide vaccine (PPSV23) 
among adults aged ≥19 years — Advisory Committee on 
Immunization Practices (ACIP), United States
•	 PPSV23	 should	be	 administered	 to	 adults	
aged 19–64 years with chronic or immuno-
suppressing medical conditions, including 
those who have asthma.
•	 Adults	aged	19–64	years	who	smoke	ciga-
rettes should receive PPSV23 and smoking 
cessation guidance.
•	 Routine	PPSV23	use	 is	 no	 longer	 recom-
mended for Alaska Natives or American 
Indians aged <65 years unless they have 
medical indications for PPSV23. However, 
in certain situations, public health authorities 
may recommend PPSV23 for Alaska Natives 
and American Indians aged 50–64 years who 
are living in areas where the risk for invasive 
pneumococcal disease is increased.
•	 All	 persons	 should	 be	 vaccinated	 with	
PPSV23 at age 65 years. Those who received 
PPSV23 before age 65 years for any indica-
tion should receive another dose of the vac-
cine at age 65 years or later if at least 5 years 
have passed since their previous dose. Those 
who receive PPSV23 at or after age 65 years 
should receive only a single dose.
•	 ACIP	does	not	recommend	routine	revacci-
nation for most persons for whom PPSV23 
is indicated. A second dose of PPSV23 is 
recommended 5 years after the first dose for 
persons aged 19–64 years with functional 
or anatomic asplenia and for persons with 
immunocompromising conditions. ACIP 
does not recommend multiple revaccinations 
because of uncertainty regarding clinical 
benefit and safety. 
clinical benefit, particularly the degree and duration 
of protection, and safety. 
Smoking cessation. Quitting smoking reduces the 
risk for pneumococcal disease. One study found that 
the risk for IPD was reduced by approximately 14% 
each year after quitting smoking and returned to a 
risk similar to that for persons who had never smoked 
in approximately 13 years (9). ACIP emphasizes that 
smoking cessation guidance should be part of the 
therapeutic plan for smokers regardless of immuni-
zation status. Professional organizations such as the 
Infectious Disease Society of America and American 
Thoracic Society also recommend smoking cessation 
counseling and pneumococcal vaccination for smok-
ers who are hospitalized with community-acquired 
pneumonia (14). Clinical practice guidelines from the 
U.S. Public Health Service for treating tobacco use 
and dependence are available at http://surgeongeneral.
gov/tobacco/treating_tobacco_use08.pdf. 
Reported by
JP Nuorti, MD, DSc, CG Whitney, MD, Div of Bacte-
rial Diseases, National Center for Immunization and 
Respiratory Diseases, CDC, for the ACIP Pneumococcal 
Vaccines Working Group.
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Clinical Vaccinology Course — 
November 5–7, 2010
CDC and six other national organizations are 
collaborating with the National Foundation for 
Infectious Diseases (NFID), Emory University School 
of Medicine, and the Emory Vaccine Center to sponsor 
a Clinical Vaccinology Course November 5–7, 2010, 
at the Hyatt Regency Bethesda in Bethesda, Maryland. 
Through lectures and interactive case presentations, 
the course will focus on new developments and 
concerns related to the use of vaccines in pediatric, 
adolescent, and adult populations. Infectious disease 
experts, including pediatricians, internists, family 
physicians, and public health professionals, will 
present the latest information on newly available 
vaccines and vaccines under development as well as 
established vaccines whose continued administration 
is essential to improving disease prevention efforts.
This course is designed specifically for physicians, 
nurses, physician assistants, pharmacists, vaccine 
program administrators, and other health-care 
professionals involved with or interested in the 
clinical use of vaccines. The course also will be of 
interest to health-care professionals involved in the 
prevention and control of infectious diseases, such as 
federal, state, and local public health officials. Course 
participants should have a knowledge of or interest in 
vaccines and vaccine-preventable diseases.
Continuing education credits will be offered. 
Information regarding the preliminary program, regis-
tration, and hotel accommodations is available online 
(http://www.nfid.org), by e-mail (idcourse@nfid.org), 
by fax (301-907-0878), by telephone (301-656-0003, 
ext. 19), or by mail (NFID, 4733 Bethesda Avenue, 
Suite 750, Bethesda, MD 20814-5228).
Preventive Medicine Residency and 
Fellowship Application Deadline — 
September 15, 2010
CDC’s Preventive Medicine Residency and 
Fellowship (PMR/F) programs are accepting 
applications from physicians for the residency 
and from veterinarians, dentists, nurses, physician 
assistants, and international medical graduates for the 
fellowship. Applicants with public health and applied 
epidemiologic practice experience who seek to become 
preventive medicine and population health specialists 
and public health leaders may apply. 
PMR/F programs prepare clinicians for leadership 
roles in public health at federal, state, and local 
levels through instruction and supervised practical 
experiences focused on translating epidemiology to 
public health practice, management, and policy and 
program development. Residents and fellows spend 
the practicum year at CDC or at a state or local health 
department.
PMR/F alumni occupy leadership positions at 
CDC, at state and local health departments, and in 
academia and private-sector agencies. Completion of 
the residency, which is accredited by the Accreditation 
Council for Graduate Medical Education for 12 
months of practicum training, qualifies graduates 
to apply for certification by the American Board of 
Preventive Medicine in Public Health and General 
Preventive Medicine.
Applications are being accepted for the class that 
begins in June 2011. The application must be submit-
ted online by September 15, 2010, and supporting 
documents must be postmarked for delivery to the 
PMR/F office by September 22, 2010. Additional 
information regarding the programs, eligibility 
criteria, and application process is available online 
(http://www.cdc.gov/prevmed), by telephone (404-
498-6140), or by e-mail (pmrcdd@cdc.gov).
Announcements
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QuickStats 
FROM THE NATIONAL CENTER FOR HEALTH STATISTICS
Hospitalization Rates for Patients Aged ≥65 Years with Septicemia 
or Sepsis,* by Age Group — National Hospital Discharge Survey, 
United States, 2000–2007 
*Septicemia or sepsis hospitalizations are those with a diagnosis code of 038, 995.91, or 995.92, based on the 
International Classification of Diseases, Ninth Revision, Clinical Modification, in any of seven diagnoses fields of 
the National Hospital Discharge Survey.
† Inpatient hospitalization rates for 2000–2007 were calculated using U.S. Census Bureau 2000–based postcensal 
civilian population estimates. Persons might have multiple inpatient septicemia or sepsis hospitalizations, all 
of which are reflected in the estimates.
Septicemia and sepsis are bloodstream infections. From 2000 to 2007, the rate of hospitalization for septicemia or sepsis for persons 
aged 65–74 years increased 57%, from 6.5 per 1,000 to 10.2, and the rate for persons aged 75–84 years increased 52%, from 11.7 
per 1,000 to 17.8. During 2000–2007, persons aged ≥85 years had higher rates of hospitalization for septicemia or sepsis than 
persons aged 65–84 years. From 2000 to 2007, rates for persons aged ≥85 years increased 18%, from 24.7 per 1,000 to 29.2.
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TABLE I. Provisional cases of infrequently reported notifiable diseases (<1,000 cases reported during the preceding year) — United States, week ending 









Total cases reported 
for previous years States reporting cases 
during current week (No.)2009 2008 2007 2006 2005
Anthrax — — 0 1 — 1 1 —
Botulism, total — 55 4 118 145 144 165 135
 foodborne — 5 1 10 17 32 20 19
 infant — 38 2 83 109 85 97 85
 other (wound and unspecified) — 12 1 25 19 27 48 31
Brucellosis 1 81 3 115 80 131 121 120 CA (1)
Chancroid 1 32 0 28 25 23 33 17 NC (1)
Cholera — 2 0 10 5 7 9 8
Cyclosporiasis§ 1 125 3 141 139 93 137 543 NY (1)
Diphtheria — — — — — — — —
Domestic arboviral diseases § ,¶:
 California serogroup virus disease — 19 4 55 62 55 67 80
 Eastern equine encephalitis virus disease — 9 1 4 4 4 8 21
 Powassan virus disease — 2 0 6 2 7 1 1
 St. Louis encephalitis virus disease — 2 1 12 13 9 10 13
 Western equine encephalitis virus disease — — — — — — — —
Haemophilus influenzae,** invasive disease (age <5 yrs):
 serotype b 1 9 0 35 30 22 29 9 VA (1)
 nonserotype b — 127 3 236 244 199 175 135
 unknown serotype 2 147 3 178 163 180 179 217 NY (1), NC (1)
Hansen disease§ — 29 2 103 80 101 66 87
Hantavirus pulmonary syndrome§ — 14 0 20 18 32 40 26
Hemolytic uremic syndrome, postdiarrheal§ 1 114 8 242 330 292 288 221 CA (1)
HIV infection, pediatric (age <13 yrs)†† — — 1 — — — — 380
Influenza-associated pediatric mortality§,§§ 2 56 1 358 90 77 43 45 LA (2)
Listeriosis 12 492 23 851 759 808 884 896 NY (1), PA (1), NC (2), GA (1), FL (2), KY (1), TX (1), CO (1), 
CA (2)
Measles¶¶ 3 46 1 71 140 43 55 66 CA (3)
Meningococcal disease, invasive***:
 A, C, Y, and W-135 1 172 4 301 330 325 318 297 NV (1)
 serogroup B — 76 2 174 188 167 193 156
 other serogroup — 7 0 23 38 35 32 27
 unknown serogroup 5 259 8 482 616 550 651 765 NYC (1), PA (1), MI (1), TX (1), CA (1)
Mumps 6 2,283 13 1,991 454 800 6,584 314 NY (3), MD (1), CA (2)
Novel influenza A virus infections††† — 1 0 43,774 2 4 NN NN
Plague — 1 0 8 3 7 17 8
Poliomyelitis, paralytic — — — 1 — — — 1
Polio virus Infection, nonparalytic§ — — — — — — NN NN
Psittacosis§ — 4 0 9 8 12 21 16
Q fever, total§,§§§ 1 75 3 114 120 171 169 136
 acute 1 57 1 94 106 — — — NE (1)
 chronic — 18 0 20 14 — — —
Rabies, human — — — 4 2 1 3 2
Rubella¶¶¶ — 6 0 3 16 12 11 11
Rubella, congenital syndrome — — — 2 — — 1 1
SARS-CoV§,**** — — — — — — — —
Smallpox§ — — — — — — — —
Streptococcal toxic-shock syndrome§ 1 117 1 161 157 132 125 129 CT (1)
Syphilis, congenital (age <1 yr)†††† — 133 8 423 431 430 349 329
Tetanus — 2 1 18 19 28 41 27
Toxic-shock syndrome (staphylococcal)§ — 52 2 74 71 92 101 90
Trichinellosis — 2 0 13 39 5 15 16
Tularemia — 58 4 93 123 137 95 154
Typhoid fever 4 246 11 397 449 434 353 324 OH (1), FL (1), CO (1), CA (1)
Vancomycin-intermediate Staphylococcus aureus§ 1 64 1 78 63 37 6 2 FL (1)
Vancomycin-resistant Staphylococcus aureus§ — 1 — 1 — 2 1 3
Vibriosis (noncholera Vibrio species infections)§ 23 435 17 789 588 549 NN NN OH (1), MD (1), VA (1), GA (1), FL (2), TN (2), AZ (1), 
WA (7), CA (6), HI (1)
Viral hemorrhagic fever§§§§ — 1 — NN NN NN NN NN
Yellow fever — — — — — — — —
See Table I footnotes on next page.
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* Ratio of current 4-week total to mean of 15 4-week totals (from previous, comparable, and subsequent 4-week periods for the 
past 5 years). The point where the hatched area begins is based on the mean and two standard deviations of these 4-week 
totals.
FIGURE I. Selected notifiable disease reports, United States, comparison of provisional 4-week 


























TABLE I. (Continued) Provisional cases of infrequently reported notifiable diseases (<1,000 cases reported during the preceding year) — United States, week 
ending August 28, 2010 (34th week)*
—: No reported cases. N: Not reportable. NN: Not Nationally Notifiable Cum: Cumulative year-to-date counts.
 * Incidence data for reporting years 2009 and 2010 are provisional, whereas data for 2005 through 2008 are finalized.
 † Calculated by summing the incidence counts for the current week, the 2 weeks preceding the current week, and the 2 weeks following the current week, for a total of 5 preceding years. 
Additional information is available at http://www.cdc.gov/ncphi/disss/nndss/phs/files/5yearweeklyaverage.pdf.
 § Not reportable in all states. Data from states where the condition is not reportable are excluded from this table except starting in 2007 for the domestic arboviral diseases, STD data, TB 
data, and influenza-associated pediatric mortality, and in 2003 for SARS-CoV.  Reporting exceptions are available at http://www.cdc.gov/ncphi/disss/nndss/phs/infdis.htm.
 ¶ Includes both neuroinvasive and nonneuroinvasive. Updated weekly from reports to the Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, Vector-Borne, and 
Enteric Diseases (ArboNET Surveillance). Data for West Nile virus are available in Table II.
 ** Data for H. influenzae (all ages, all serotypes) are available in Table II.
 †† Updated monthly from reports to the Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. Implementation of HIV reporting influences 
the number of cases reported. Updates of pediatric HIV data have been temporarily suspended until upgrading of the national HIV/AIDS surveillance data management system is 
completed. Data for HIV/AIDS, when available, are displayed in Table IV, which appears quarterly.
 §§ Updated weekly from reports to the Influenza Division, National Center for Immunization and Respiratory Diseases. Since April 26, 2009, a total of 286 influenza-associated pediatric 
deaths associated with 2009 influenza A (H1N1) virus infection have been reported. Since August 30, 2009, a total of 281 influenza-associated pediatric deaths occurring during the 
2009–10 influenza season have been reported. A total of 133 influenza-associated pediatric deaths occurring during the 2008-09 influenza season have been reported.
 ¶¶ The three measles cases reported for the current week were imported.
 *** Data for meningococcal disease (all serogroups) are available in Table II.
 ††† CDC discontinued reporting of individual confirmed and probable cases of 2009 pandemic influenza A (H1N1) virus infections on July 24, 2009. During 2009, three cases of novel 
influenza A virus infections, unrelated to the 2009 pandemic influenza A (H1N1) virus, were reported to CDC. The one case of novel influenza A virus infection reported to CDC during 
2010 was identified as swine influenza A (H3N2) virus and is unrelated to pandemic influenza A (H1N1) virus.  Total case count for 2009 was provided by the Influenza Division,  National 
Center for Immunization and Respiratory Diseases (NCIRD).
 §§§ In 2009, Q fever acute and chronic reporting categories were recognized as a result of revisions to the Q fever case definition. Prior to that time, case counts were not differentiated with 
respect to acute and chronic Q fever cases.
 ¶¶¶ No rubella cases were reported for the current week.
 **** Updated weekly from reports to the Division of Viral and Rickettsial Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases.
 †††† Updated weekly from reports to the Division of STD Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
 §§§§ There was one case of viral hemorrhagic fever reported during week 12. The one case report was confirmed as lassa fever. See Table II for dengue hemorrhagic fever.
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TABLE II. Provisional cases of selected notifiable diseases, United States, weeks ending August 28, 2010, and August 29, 2009 (34th week)*
Reporting area
Chlamydia trachomatis infection Cryptosporidiosis
Current  
week






Previous 52 weeks Cum  
2010
Cum  
2009Med Max Med Max
United States 13,226 22,794 26,156 750,153 824,675 147 122 267 4,361 4,548
New England 574 745 1,396 25,472 26,457 5 8 58 293 285
Connecticut — 220 736 6,053 7,586 — 0 52 52 38
Maine† 50 49 75 1,640 1,591 2 1 7 53 32
Massachusetts 416 397 638 13,301 12,729 — 3 15 91 109
New Hampshire 54 40 116 1,513 1,399 1 1 6 40 53
Rhode Island† 46 66 116 2,162 2,395 — 0 8 9 7
Vermont† 8 24 63 803 757 2 1 9 48 46
Mid. Atlantic 3,358 3,182 4,619 109,749 103,123 22 15 38 510 529
New Jersey 412 456 698 16,270 16,196 — 0 3 — 38
New York (Upstate) 874 674 2,530 22,025 19,708 14 3 16 130 127
New York City 1,430 1,188 2,144 41,103 38,416 — 1 5 47 60
Pennsylvania 642 877 1,091 30,351 28,803 8 9 25 333 304
E.N. Central 1,106 3,526 4,413 112,368 132,915 31 29 70 1,062 1,101
Illinois 15 851 1,322 23,472 40,662 — 2 7 95 105
Indiana — 356 786 12,029 15,610 — 4 10 116 189
Michigan 678 891 1,417 31,685 30,482 3 6 12 210 179
Ohio 159 964 1,077 31,710 32,238 19 7 24 293 269
Wisconsin 254 404 495 13,472 13,923 9 9 39 348 359
W.N. Central 263 1,330 1,592 43,414 47,094 24 22 54 746 685
Iowa 16 183 293 6,356 6,431 3 4 18 200 153
Kansas 32 188 381 6,108 7,247 7 2 7 93 67
Minnesota — 275 337 8,814 9,505 — 3 30 98 179
Missouri 201 490 606 16,061 17,240 — 3 18 157 132
Nebraska† — 95 237 3,072 3,564 14 2 12 118 63
North Dakota — 34 93 1,083 1,114 — 0 18 16 7
South Dakota 14 59 82 1,920 1,993 — 2 8 64 84
S. Atlantic 2,988 4,486 5,681 147,381 168,525 14 19 51 652 683
Delaware 72 87 156 2,747 3,101 — 0 2 3 5
District of Columbia — 100 177 3,199 4,676 — 0 1 2 5
Florida 634 1,411 1,669 48,252 49,185 8 8 24 243 230
Georgia — 381 1,323 10,170 27,178 2 5 31 197 245
Maryland† — 452 1,031 14,425 14,955 2 1 3 23 31
North Carolina 759 802 1,562 28,269 28,155 — 1 12 53 71
South Carolina† 541 516 694 17,680 18,205 2 1 8 53 42
Virginia† 882 594 902 20,246 20,660 — 2 8 67 44
West Virginia 100 68 137 2,393 2,410 — 0 2 11 10
E.S. Central 516 1,712 2,410 56,199 62,538 4 4 11 151 136
Alabama† — 470 661 16,012 18,133 — 1 5 56 43
Kentucky 242 301 642 10,300 8,620 2 1 6 52 38
Mississippi — 385 780 11,387 15,886 — 0 3 7 12
Tennessee† 274 581 732 18,500 19,899 2 1 5 36 43
W.S. Central 1,703 2,905 4,578 97,728 108,100 5 8 39 222 322
Arkansas† 313 240 402 7,042 9,557 — 1 4 22 34
Louisiana — 23 1,055 2,922 19,342 1 1 5 28 34
Oklahoma 441 262 1,376 10,606 9,793 4 1 9 55 73
Texas† 949 2,233 3,201 77,158 69,408 — 4 30 117 181
Mountain 393 1,459 2,081 45,057 51,098 15 10 20 338 367
Arizona 87 467 713 13,195 17,103 — 0 3 21 25
Colorado 94 383 709 11,902 11,585 6 2 9 89 96
Idaho† — 64 191 1,985 2,452 1 2 6 57 56
Montana† 21 58 75 1,922 1,990 1 1 4 33 38
Nevada† 157 177 337 6,381 6,756 — 0 2 14 15
New Mexico† — 165 453 4,531 5,883 1 2 8 65 96
Utah 23 117 175 3,884 4,071 6 1 4 47 26
Wyoming† 11 38 70 1,257 1,258 — 0 2 12 15
Pacific 2,325 3,472 5,350 112,785 124,825 27 12 27 387 440
Alaska — 107 147 3,786 3,532 — 0 1 2 4
California 2,012 2,735 4,406 90,758 95,600 17 8 20 226 250
Hawaii 1 112 158 3,687 4,056 — 0 0 — 1
Oregon — 58 468 1,367 7,104 4 2 7 101 137
Washington 312 396 497 13,187 14,533 6 1 8 58 48
Territories
American Samoa — 0 0 — — N 0 0 N N
C.N.M.I. — — — — — — — — — —
Guam — 4 31 173 248 — 0 0 — —
Puerto Rico — 95 266 3,388 5,213 N 0 0 N N
U.S. Virgin Islands — 8 15 132 359 — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional. Data for HIV/AIDS, AIDS, and TB, when available, are displayed in Table IV, which appears quarterly.
† Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending August 28, 2010, and August 29, 2009 (34th week)*
Dengue Virus Infection
Reporting area
Dengue Fever† Dengue Hemorrhagic Fever§
Current  
week






Previous 52 weeks Cum  
2010
Cum  
2009Med Max Med Max
United States — 2 19 213 NN — 0 1 2 NN
New England — 0 1 2 NN — 0 0 — NN
Connecticut — 0 0 — NN — 0 0 — NN
Maine¶ — 0 1 1 NN — 0 0 — NN
Massachusetts — 0 0 — NN — 0 0 — NN
New Hampshire — 0 0 — NN — 0 0 — NN
Rhode Island¶ — 0 0 — NN — 0 0 — NN
Vermont¶ — 0 1 1 NN — 0 0 — NN
Mid. Atlantic — 0 7 60 NN — 0 0 — NN
New Jersey — 0 0 — NN — 0 0 — NN
New York (Upstate) — 0 0 — NN — 0 0 — NN
New York City — 0 5 50 NN — 0 0 — NN
Pennsylvania — 0 2 10 NN — 0 0 — NN
E.N. Central — 0 2 8 NN — 0 0 — NN
Illinois — 0 0 — NN — 0 0 — NN
Indiana — 0 0 — NN — 0 0 — NN
Michigan — 0 0 — NN — 0 0 — NN
Ohio — 0 2 5 NN — 0 0 — NN
Wisconsin — 0 1 3 NN — 0 0 — NN
W.N. Central — 0 2 9 NN — 0 0 — NN
Iowa — 0 1 1 NN — 0 0 — NN
Kansas — 0 0 — NN — 0 0 — NN
Minnesota — 0 2 8 NN — 0 0 — NN
Missouri — 0 0 — NN — 0 0 — NN
Nebraska¶ — 0 0 — NN — 0 0 — NN
North Dakota — 0 0 — NN — 0 0 — NN
South Dakota — 0 0 — NN — 0 0 — NN
S. Atlantic — 0 14 116 NN — 0 1 1 NN
Delaware — 0 0 — NN — 0 0 — NN
District of Columbia — 0 0 — NN — 0 0 — NN
Florida — 0 13 99 NN — 0 1 1 NN
Georgia — 0 2 6 NN — 0 0 — NN
Maryland¶ — 0 0 — NN — 0 0 — NN
North Carolina — 0 1 1 NN — 0 0 — NN
South Carolina¶ — 0 3 8 NN — 0 0 — NN
Virginia¶ — 0 0 — NN — 0 0 — NN
West Virginia — 0 1 2 NN — 0 0 — NN
E.S. Central — 0 1 1 NN — 0 0 — NN
Alabama¶ — 0 0 — NN — 0 0 — NN
Kentucky — 0 0 — NN — 0 0 — NN
Mississippi — 0 0 — NN — 0 0 — NN
Tennessee¶ — 0 1 1 NN — 0 0 — NN
W.S. Central — 0 0 — NN — 0 1 1 NN
Arkansas¶ — 0 0 — NN — 0 1 1 NN
Louisiana — 0 0 — NN — 0 0 — NN
Oklahoma — 0 0 — NN — 0 0 — NN
Texas¶ — 0 0 — NN — 0 0 — NN
Mountain — 0 1 8 NN — 0 0 — NN
Arizona — 0 1 2 NN — 0 0 — NN
Colorado — 0 0 — NN — 0 0 — NN
Idaho¶ — 0 0 — NN — 0 0 — NN
Montana¶ — 0 1 2 NN — 0 0 — NN
Nevada¶ — 0 1 3 NN — 0 0 — NN
New Mexico¶ — 0 1 1 NN — 0 0 — NN
Utah — 0 0 — NN — 0 0 — NN
Wyoming¶ — 0 0 — NN — 0 0 — NN
Pacific — 0 2 9 NN — 0 0 — NN
Alaska — 0 0 — NN — 0 0 — NN
California — 0 1 4 NN — 0 0 — NN
Hawaii — 0 0 — NN — 0 0 — NN
Oregon — 0 0 — NN — 0 0 — NN
Washington — 0 2 5 NN — 0 0 — NN
Territories
American Samoa — 0 0 — NN — 0 0 — NN
C.N.M.I. — — — — NN — — — — NN
Guam — 0 0 — NN — 0 0 — NN
Puerto Rico — 17 83 1,114 NN — 0 3 27 NN
U.S. Virgin Islands — 0 0 — NN — 0 0 — NN
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Dengue Fever includes cases that meet criteria for Dengue Fever with hemorrhage.
§ DHF includes cases that meet criteria for dengue shock syndrome (DSS), a more severe form of DHF.
¶ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending August 28, 2010, and August 29, 2009 (34th week)*
Ehrlichiosis/Anaplasmosis†
Reporting area
Ehrlichia chaffeensis Anaplasma phagocytophilum Undetermined
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 6 11 181 401 666 5 14 309 421 650 — 2 35 67 136
New England — 0 3 3 36 — 2 17 50 195 — 0 2 6 2
Connecticut — 0 0 — — — 0 13 18 2 — 0 2 4 —
Maine§ — 0 1 2 3 — 0 2 13 11 — 0 0 — —
Massachusetts — 0 0 — 9 — 0 4 — 82 — 0 0 — —
New Hampshire — 0 1 1 3 — 0 3 8 15 — 0 1 2 1
Rhode Island§ — 0 2 — 20 — 0 7 11 85 — 0 0 — 1
Vermont§ — 0 0 — 1 — 0 0 — — — 0 0 — —
Mid. Atlantic — 1 15 33 117 3 4 17 125 198 — 0 2 2 38
New Jersey — 0 6 — 70 — 0 2 1 59 — 0 0 — —
New York (Upstate) — 1 15 19 29 3 3 17 122 134 — 0 1 2 4
New York City — 0 3 13 7 — 0 1 2 4 — 0 0 — 1
Pennsylvania — 0 5 1 11 — 0 1 — 1 — 0 2 — 33
E.N. Central — 0 4 20 72 — 3 26 180 232 — 1 4 34 58
Illinois — 0 2 9 32 — 0 0 — 6 — 0 2 3 3
Indiana — 0 0 — — — 0 0 — — — 0 2 17 31
Michigan — 0 1 1 4 — 0 0 — — — 0 1 2 —
Ohio — 0 2 4 10 — 0 1 1 1 — 0 0 — 2
Wisconsin — 0 3 6 26 — 3 26 179 225 — 0 3 12 22
W.N. Central 1 1 11 81 127 — 0 261 9 6 — 0 30 15 16
Iowa — 0 0 — — — 0 0 — — — 0 0 — —
Kansas 1 0 1 6 6 — 0 0 — 1 — 0 0 — —
Minnesota — 0 6 — 1 — 0 261 — 3 — 0 30 — 3
Missouri — 1 10 74 118 — 0 3 9 2 — 0 4 15 13
Nebraska§ — 0 1 1 2 — 0 1 — — — 0 0 — —
North Dakota — 0 0 — — — 0 0 — — — 0 0 — —
South Dakota — 0 0 — — — 0 0 — — — 0 0 — —
S. Atlantic 3 4 19 183 181 1 0 7 43 13 — 0 1 3 2
Delaware — 0 3 15 15 — 0 1 4 2 — 0 0 — —
District of Columbia — 0 0 — — — 0 0 — — — 0 0 — —
Florida — 0 2 7 8 — 0 1 2 2 — 0 0 — —
Georgia — 0 4 15 15 — 0 1 1 1 — 0 1 1 —
Maryland§ — 0 3 17 32 1 0 2 12 3 — 0 1 2 —
North Carolina 1 1 13 69 47 — 0 4 16 3 — 0 0 — —
South Carolina§ — 0 2 3 8 — 0 0 — — — 0 0 — —
Virginia§ 2 1 13 57 55 — 0 2 8 2 — 0 0 — 2
West Virginia — 0 0 — 1 — 0 0 — — — 0 1 — —
E.S. Central 2 1 10 63 103 — 0 2 12 3 — 0 2 6 20
Alabama§ — 0 2 9 6 — 0 2 5 1 — 0 0 — —
Kentucky — 0 2 9 9 — 0 0 — — — 0 0 — —
Mississippi — 0 1 2 6 — 0 1 1 — — 0 0 — —
Tennessee§ 2 1 10 43 82 — 0 2 6 2 — 0 2 6 20
W.S. Central — 0 141 17 28 1 0 23 2 1 — 0 1 1 —
Arkansas§ — 0 34 2 4 — 0 6 — — — 0 0 — —
Louisiana — 0 1 1 — — 0 0 — — — 0 0 — —
Oklahoma — 0 105 11 23 1 0 16 2 1 — 0 0 — —
Texas§ — 0 2 3 1 — 0 1 — — — 0 1 1 —
Mountain — 0 0 — — — 0 0 — — — 0 1 — —
Arizona — 0 0 — — — 0 0 — — — 0 1 — —
Colorado — 0 0 — — — 0 0 — — — 0 0 — —
Idaho§ — 0 0 — — — 0 0 — — — 0 0 — —
Montana§ — 0 0 — — — 0 0 — — — 0 0 — —
Nevada§ — 0 0 — — — 0 0 — — — 0 0 — —
New Mexico§ — 0 0 — — — 0 0 — — — 0 0 — —
Utah — 0 0 — — — 0 0 — — — 0 0 — —
Wyoming§ — 0 0 — — — 0 0 — — — 0 0 — —
Pacific — 0 1 1 2 — 0 0 — 2 — 0 1 — —
Alaska — 0 0 — — — 0 0 — — — 0 0 — —
California — 0 1 1 2 — 0 0 — 2 — 0 1 — —
Hawaii — 0 0 — — — 0 0 — — — 0 0 — —
Oregon — 0 0 — — — 0 0 — — — 0 0 — —
Washington — 0 0 — — — 0 0 — — — 0 0 — —
Territories
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 0 — — — 0 0 — —
Puerto Rico — 0 0 — — — 0 0 — — — 0 0 — —
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Cumulative total E. ewingii cases reported for year 2010 = 7.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending August 28, 2010, and August 29, 2009 (34th week)*
Reporting area
Giardiasis Gonorrhea
Haemophilus influenzae, invasive†  
All ages, all serotypes
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 273 336 666 10,940 11,666 3,097 5,341 6,656 174,562 200,014 23 58 171 1,934 2,006
New England 5 31 65 952 1,040 73 100 196 3,347 3,143 — 3 21 110 133
Connecticut — 5 15 174 185 — 45 169 1,458 1,440 — 0 15 24 39
Maine§ 4 4 11 132 142 3 3 11 120 86 — 0 2 9 15
Massachusetts — 13 36 391 444 55 42 72 1,457 1,289 — 2 8 57 62
New Hampshire — 3 11 94 126 5 2 7 101 73 — 0 2 7 7
Rhode Island§ — 1 7 35 38 10 5 13 166 225 — 0 1 7 6
Vermont§ 1 4 14 126 105 — 1 17 45 30 — 0 1 6 4
Mid. Atlantic 53 60 112 1,876 2,136 693 666 941 22,413 20,350 7 11 34 386 393
New Jersey — 6 15 192 286 96 99 151 3,460 3,123 — 2 7 55 91
New York (Upstate) 35 23 84 689 782 145 104 422 3,496 3,582 3 3 20 104 99
New York City 8 16 30 538 543 272 224 394 7,843 7,208 3 2 6 79 44
Pennsylvania 10 15 37 457 525 180 217 283 7,614 6,437 1 4 9 148 159
E.N. Central 31 49 92 1,654 1,820 309 973 1,536 30,568 42,437 1 9 20 318 317
Illinois — 11 22 319 401 5 193 441 5,334 13,615 — 2 9 85 124
Indiana — 6 14 159 171 — 96 214 3,390 5,051 — 1 6 64 54
Michigan 8 13 25 414 419 195 249 502 8,910 9,878 — 0 4 25 16
Ohio 21 17 28 542 513 51 315 372 9,983 10,423 1 2 6 79 73
Wisconsin 2 7 23 220 316 58 92 194 2,951 3,470 — 2 5 65 50
W.N. Central 21 25 165 915 1,082 84 274 367 8,774 9,957 2 3 24 112 114
Iowa 5 5 10 188 201 5 31 53 1,058 1,132 — 0 1 1 —
Kansas 7 4 8 149 105 6 39 83 1,270 1,721 2 0 1 12 13
Minnesota — 0 135 136 250 — 41 64 1,235 1,541 — 0 17 25 35
Missouri — 8 23 225 340 73 123 172 4,203 4,346 — 1 6 52 43
Nebraska§ 9 4 8 149 116 — 22 50 723 899 — 0 2 14 18
North Dakota — 0 8 16 8 — 2 11 76 84 — 0 4 8 5
South Dakota — 2 10 52 62 — 6 16 209 234 — 0 0 — —
S. Atlantic 79 75 143 2,466 2,320 810 1,299 1,651 42,772 50,022 10 14 27 519 540
Delaware — 0 4 21 18 12 19 34 638 603 — 0 1 5 3
District of Columbia — 1 4 23 42 — 39 86 1,234 1,831 — 0 1 2 2
Florida 63 38 87 1,347 1,252 212 378 482 12,980 14,278 1 3 9 122 172
Georgia — 13 51 485 474 — 141 494 3,584 9,058 2 3 9 128 103
Maryland§ 4 6 12 176 177 — 128 237 4,184 4,024 2 1 6 40 64
North Carolina N 0 0 N N 253 259 596 9,440 9,615 2 2 9 90 66
South Carolina§ 5 2 7 94 58 152 155 230 5,293 5,619 — 2 7 60 46
Virginia§ 7 8 36 298 268 170 161 271 5,095 4,652 1 2 4 56 61
West Virginia — 1 5 22 31 11 8 20 324 342 2 0 5 16 23
E.S. Central — 5 22 150 261 140 477 698 15,331 17,999 — 3 12 117 130
Alabama§ — 4 8 98 130 — 137 216 4,711 5,107 — 0 3 19 32
Kentucky N 0 0 N N 74 77 156 2,675 2,523 — 0 2 23 18
Mississippi N 0 0 N N — 111 216 3,172 4,959 — 0 2 9 7
Tennessee§ — 2 18 52 131 66 151 195 4,773 5,410 — 2 10 66 73
W.S. Central 3 9 18 231 323 524 772 1,227 25,915 31,548 2 2 20 91 86
Arkansas§ 2 2 9 76 90 133 72 139 2,152 2,941 — 0 3 12 15
Louisiana 1 3 10 92 132 — 1 343 910 6,307 — 0 3 17 15
Oklahoma — 2 7 63 101 136 80 359 3,040 3,075 2 1 15 55 53
Texas§ N 0 0 N N 255 571 962 19,813 19,225 — 0 2 7 3
Mountain 26 30 60 980 1,037 64 169 266 5,340 6,024 — 5 15 206 180
Arizona 1 3 7 95 131 10 60 109 1,549 1,997 — 2 10 77 57
Colorado 13 13 27 457 313 23 51 127 1,675 1,813 — 1 5 63 52
Idaho§ 2 4 9 126 115 — 2 6 53 71 — 0 2 12 3
Montana§ 1 2 11 70 78 — 2 6 75 50 — 0 1 2 1
Nevada§ 8 1 11 52 69 30 29 94 1,147 1,159 — 0 2 5 14
New Mexico§ 1 2 5 57 93 — 20 41 613 692 — 1 5 26 25
Utah — 4 13 99 197 1 6 15 204 194 — 0 4 16 25
Wyoming§ — 1 5 24 41 — 1 4 24 48 — 0 2 5 3
Pacific 55 53 133 1,716 1,647 400 579 788 20,102 18,534 1 2 9 75 113
Alaska — 2 7 60 65 — 23 36 812 626 — 0 2 15 13
California 41 33 61 1,090 1,094 342 482 692 17,026 15,225 — 0 4 12 39
Hawaii — 0 4 16 14 4 13 24 456 418 — 0 2 3 26
Oregon 4 9 15 286 245 — 3 43 106 715 1 1 5 41 32
Washington 10 9 75 264 229 54 48 66 1,702 1,550 — 0 4 4 3
Territories
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 1 2 3 — 0 4 20 14 — 0 0 — —
Puerto Rico — 1 8 17 117 — 4 14 164 173 — 0 1 1 3
U.S. Virgin Islands — 0 0 — — — 1 4 25 92 — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Data for H. influenzae (age <5 yrs for serotype b, nonserotype b, and unknown serotype) are available in Table I.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending August 28, 2010, and August 29, 2009 (34th week)*

















Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 20 30 69 959 1,309 46 58 204 1,944 2,180 9 15 44 542 493
New England — 2 5 66 70 — 1 5 37 40 — 1 4 22 46
Connecticut — 0 2 18 14 — 0 2 11 11 — 0 3 15 36
Maine† — 0 1 7 1 — 0 2 11 9 — 0 1 — 1
Massachusetts — 1 4 34 44 — 0 2 8 16 — 0 1 7 8
New Hampshire — 0 1 1 6 — 0 2 5 4 N 0 0 N N
Rhode Island† — 0 4 6 3 U 0 0 U U U 0 0 U U
Vermont† — 0 0 — 2 — 0 1 2 — — 0 0 — 1
Mid. Atlantic 2 4 10 128 183 — 5 10 201 239 2 2 6 71 68
New Jersey — 0 3 11 52 — 1 5 50 73 — 0 2 7 4
New York (Upstate) 1 1 3 38 31 — 1 6 37 38 2 1 4 41 32
New York City — 1 4 44 57 — 2 4 60 45 — 0 1 — 4
Pennsylvania 1 1 6 35 43 — 1 5 54 83 — 0 3 23 28
E.N. Central 5 4 10 124 210 3 8 15 281 307 — 2 8 101 65
Illinois — 1 3 26 97 — 2 6 58 76 — 0 1 1 4
Indiana — 0 2 15 15 — 1 5 39 48 — 0 2 18 13
Michigan — 1 4 37 48 — 2 6 75 98 — 1 6 70 22
Ohio 5 0 4 24 28 3 2 6 76 68 — 0 1 7 23
Wisconsin — 0 3 22 22 — 1 3 33 17 — 0 1 5 3
W.N. Central 1 1 12 44 80 — 2 15 80 92 — 0 11 21 9
Iowa — 0 3 5 26 — 0 2 11 26 — 0 4 1 3
Kansas — 0 2 9 7 — 0 2 4 5 — 0 0 — 1
Minnesota — 0 12 13 14 — 0 13 6 17 — 0 9 9 2
Missouri — 0 3 13 13 — 1 5 49 30 — 0 1 9 —
Nebraska† 1 0 1 4 17 — 0 2 9 12 — 0 1 2 2
North Dakota — 0 1 — — — 0 0 — — — 0 1 — —
South Dakota — 0 0 — 3 — 0 1 1 2 — 0 0 — 1
S. Atlantic 5 8 14 238 275 27 16 40 570 596 4 4 7 115 111
Delaware — 0 1 5 3 — 0 2 18 22 U 0 0 U U
District of Columbia — 0 1 1 1 — 0 1 3 9 — 0 1 2 —
Florida 2 3 8 86 119 10 5 11 197 195 2 1 4 38 27
Georgia — 1 3 27 33 1 3 7 97 96 — 0 2 6 29
Maryland† — 0 4 16 29 1 1 6 38 54 — 0 2 14 16
North Carolina 1 0 5 41 31 8 1 15 65 79 2 1 3 32 13
South Carolina† 1 1 4 26 37 — 1 4 38 37 — 0 0 — 1
Virginia† 1 1 6 34 21 2 2 14 72 58 — 0 2 9 7
West Virginia — 0 2 2 1 5 0 14 42 46 — 0 5 14 18
E.S. Central 1 1 3 27 29 3 7 13 216 214 1 3 7 87 65
Alabama† — 0 1 5 7 — 1 5 39 65 — 0 2 3 5
Kentucky 1 0 2 12 6 1 2 7 74 49 — 2 5 60 39
Mississippi — 0 1 1 8 — 0 3 20 19 U 0 0 U U
Tennessee† — 0 2 9 8 2 3 6 83 81 1 0 4 24 21
W.S. Central — 2 19 73 123 4 9 109 280 379 1 1 14 47 39
Arkansas† — 0 3 — 6 — 1 4 31 48 — 0 1 — 1
Louisiana — 0 2 6 3 — 1 5 30 41 — 0 1 4 6
Oklahoma — 0 3 — 3 3 1 19 58 66 1 0 12 15 9
Texas† — 2 18 67 111 1 5 87 161 224 — 1 3 28 23
Mountain 2 3 9 105 110 3 2 8 84 93 — 1 5 32 36
Arizona 1 1 5 49 45 — 0 2 22 35 U 0 0 U U
Colorado 1 1 3 24 38 — 0 3 18 17 — 0 2 6 23
Idaho† — 0 2 6 3 1 0 1 6 7 — 0 2 8 2
Montana† — 0 1 4 5 — 0 1 1 — — 0 0 — 1
Nevada† — 0 2 10 7 2 1 3 29 21 — 0 1 3 2
New Mexico† — 0 1 3 7 — 0 1 3 5 — 0 2 7 5
Utah — 0 2 6 3 — 0 1 5 4 — 0 1 8 3
Wyoming† — 0 3 3 2 — 0 0 — 4 — 0 0 — —
Pacific 4 5 16 154 229 6 6 20 195 220 1 1 6 46 54
Alaska — 0 1 1 2 — 0 1 2 2 U 0 2 U U
California 4 4 15 125 178 5 4 17 136 155 1 0 4 21 27
Hawaii — 0 2 1 8 — 0 1 — 5 U 0 0 U U
Oregon — 0 2 13 10 — 1 4 28 28 — 0 3 10 15
Washington — 0 2 14 31 1 1 4 29 30 — 0 6 15 12
Territories
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 6 13 4 — 0 6 29 42 — 0 6 25 33
Puerto Rico — 0 1 3 20 — 0 5 10 21 — 0 0 — —
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending August 28, 2010, and August 29, 2009 (34th week)*
Reporting area
Legionellosis Lyme disease Malaria
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 40 60 111 1,831 2,066 245 425 2,340 16,260 27,563 22 25 89 843 918
New England — 3 9 115 137 62 128 361 4,532 9,826 — 1 4 43 40
Connecticut — 0 3 23 37 2 43 179 1,624 3,397 — 0 1 1 5
Maine† — 0 1 6 6 60 12 76 411 550 — 0 1 5 2
Massachusetts — 1 7 67 69 — 41 127 1,456 4,318 — 1 3 30 25
New Hampshire — 0 3 7 9 — 22 57 786 1,066 — 0 1 1 3
Rhode Island† — 0 3 5 10 — 1 18 35 188 — 0 1 4 2
Vermont† — 0 2 7 6 — 4 26 220 307 — 0 1 2 3
Mid. Atlantic 15 16 44 445 750 136 199 626 8,005 11,818 3 7 17 223 257
New Jersey — 2 13 47 133 1 45 159 1,882 4,043 — 0 5 1 68
New York (Upstate) 8 5 19 153 225 95 55 577 1,969 2,574 3 1 4 47 35
New York City — 2 12 71 154 — 1 37 9 753 — 4 12 138 113
Pennsylvania 7 6 16 174 238 40 75 344 4,145 4,448 — 1 3 37 41
E.N. Central 10 12 36 412 426 1 23 114 1,023 2,406 — 2 9 90 128
Illinois — 2 11 73 67 — 1 9 52 115 — 1 7 29 54
Indiana — 1 6 57 36 — 1 7 48 68 — 0 2 7 19
Michigan — 3 14 91 88 — 1 14 72 68 — 0 4 19 19
Ohio 10 5 12 153 183 — 0 5 19 29 — 0 5 31 28
Wisconsin — 1 11 38 52 1 18 101 832 2,126 — 0 1 4 8
W.N. Central 1 2 19 73 79 — 3 1,395 87 183 — 1 11 41 41
Iowa — 0 3 7 16 — 0 10 61 93 — 0 1 7 10
Kansas — 0 2 6 5 — 0 1 5 16 — 0 2 7 5
Minnesota — 0 16 23 8 — 0 1,380 — 68 — 0 11 3 13
Missouri — 0 4 22 39 — 0 1 3 3 — 0 3 10 8
Nebraska† 1 0 2 7 9 — 0 2 9 2 — 0 2 12 4
North Dakota — 0 1 4 1 — 0 15 8 — — 0 1 — —
South Dakota — 0 1 4 1 — 0 1 1 1 — 0 2 2 1
S. Atlantic 7 11 25 335 319 37 62 155 2,364 3,042 12 6 36 234 248
Delaware — 0 3 11 12 7 12 30 469 752 — 0 1 2 3
District of Columbia — 0 4 12 14 — 0 3 16 46 — 0 3 7 10
Florida 4 4 10 118 101 3 2 11 55 42 7 2 6 86 67
Georgia — 1 4 31 30 — 0 2 8 36 — 0 2 3 55
Maryland† 2 2 12 67 82 7 28 70 984 1,517 2 1 19 54 55
North Carolina — 1 7 36 38 — 1 9 65 70 1 0 13 33 19
South Carolina† — 0 2 8 6 2 1 3 26 25 — 0 1 3 3
Virginia† 1 1 6 43 32 18 14 79 663 491 2 1 5 45 34
West Virginia — 0 3 9 4 — 0 33 78 63 — 0 2 1 2
E.S. Central 1 2 10 89 87 — 1 4 31 22 — 0 3 20 28
Alabama† — 0 2 9 11 — 0 1 — 2 — 0 2 3 8
Kentucky — 0 4 19 35 — 0 1 2 1 — 0 3 5 8
Mississippi — 0 3 8 4 — 0 0 — — — 0 2 2 3
Tennessee† 1 1 6 53 37 — 1 4 29 19 — 0 2 10 9
W.S. Central 2 3 14 82 71 — 3 44 45 117 2 1 31 53 43
Arkansas† — 0 2 11 5 — 0 0 — — — 0 1 1 3
Louisiana — 0 3 5 7 — 0 0 — — — 0 1 1 5
Oklahoma 1 0 4 10 3 — 0 2 — — 1 0 1 4 1
Texas† 1 2 10 56 56 — 3 42 45 117 1 1 30 47 34
Mountain 1 3 9 103 81 1 0 3 15 45 1 1 3 40 38
Arizona — 1 6 36 30 — 0 1 3 3 1 0 2 18 5
Colorado — 1 5 22 12 1 0 1 2 1 — 0 1 12 23
Idaho† — 0 1 3 3 — 0 1 5 13 — 0 1 1 2
Montana† — 0 1 4 5 — 0 0 — 3 — 0 1 2 4
Nevada† 1 0 2 18 10 — 0 1 — 12 — 0 1 3 —
New Mexico† — 0 2 4 3 — 0 1 3 4 — 0 1 1 —
Utah — 0 3 12 17 — 0 1 2 7 — 0 1 3 4
Wyoming† — 0 2 4 1 — 0 1 — 2 — 0 0 — —
Pacific 3 5 19 177 116 8 4 10 158 104 4 3 19 99 95
Alaska — 0 2 2 1 — 0 1 4 4 — 0 1 2 2
California 3 3 19 150 89 7 3 9 111 65 4 2 13 69 70
Hawaii — 0 1 1 1 N 0 0 N N — 0 1 1 1
Oregon — 0 3 9 10 — 1 3 36 30 — 0 1 6 9
Washington — 0 4 15 15 1 0 3 7 5 — 0 5 21 13
Territories
American Samoa — 0 0 — — N 0 0 N N — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 0 — — — 0 0 — —
Puerto Rico — 0 1 — 1 N 0 0 N N — 0 1 1 3
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending August 28, 2010, and August 29, 2009 (34th week)*
Reporting area
Meningococcal disease, invasive† 
All groups Pertussis Rabies, animal
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 6 16 43 514 653 247 290 1,756 10,396 10,276 52 72 147 2,261 3,491
New England — 0 2 13 24 — 8 17 251 464 2 4 24 159 223
Connecticut — 0 2 2 3 — 1 7 63 34 — 1 22 59 93
Maine§ — 0 1 3 3 — 0 5 24 68 1 1 4 41 36
Massachusetts — 0 1 3 12 — 4 10 134 269 — 0 0 — —
New Hampshire — 0 1 — 1 — 0 3 7 59 — 0 5 10 25
Rhode Island§ — 0 0 — 4 — 0 8 19 25 — 0 5 14 29
Vermont§ — 0 1 5 1 — 0 1 4 9 1 1 5 35 40
Mid. Atlantic 2 1 4 44 72 38 21 61 772 805 7 18 41 687 402
New Jersey — 0 2 9 12 — 3 8 67 165 — 0 0 — —
New York (Upstate) — 0 3 9 16 14 7 27 296 129 7 9 22 358 290
New York City 1 0 2 11 12 2 0 11 44 58 — 1 12 105 12
Pennsylvania 1 0 2 15 32 22 8 37 365 453 — 3 24 224 100
E.N. Central 1 3 8 88 115 52 68 126 2,622 2,106 8 2 26 185 173
Illinois — 0 4 16 30 — 11 27 418 478 4 1 11 96 63
Indiana — 0 3 21 24 — 9 26 337 232 — 0 1 — 25
Michigan 1 0 2 13 18 12 22 45 717 507 1 1 5 51 51
Ohio — 1 2 21 26 40 20 69 945 761 3 0 12 38 34
Wisconsin — 0 2 17 17 — 4 11 205 128 — 0 0 — —
W.N. Central — 1 6 36 51 73 25 627 1,047 1,557 9 5 18 179 277
Iowa — 0 3 8 7 — 5 24 241 157 — 0 2 7 25
Kansas — 0 2 5 9 — 3 9 94 174 2 1 4 46 59
Minnesota — 0 2 2 9 66 0 601 335 319 4 0 9 24 39
Missouri — 0 3 15 18 — 8 25 209 756 — 1 6 52 45
Nebraska§ — 0 2 5 5 7 2 10 115 107 3 1 6 40 65
North Dakota — 0 1 1 1 — 0 30 30 17 — 0 7 10 4
South Dakota — 0 2 — 2 — 1 5 23 27 — 0 4 — 40
S. Atlantic — 3 7 100 119 18 26 74 935 1,123 22 22 85 712 1,495
Delaware — 0 1 1 2 1 0 4 9 10 — 0 0 — —
District of Columbia — 0 0 — — — 0 1 4 3 — 0 0 — —
Florida — 1 5 44 40 12 5 28 211 358 — 0 72 72 161
Georgia — 0 2 9 22 — 3 15 137 178 — 0 13 — 280
Maryland§ — 0 1 4 6 — 2 8 69 99 — 6 15 220 269
North Carolina — 0 2 14 22 — 1 32 124 147 — 0 15 — 336
South Carolina§ — 0 1 9 11 3 5 19 232 184 — 0 0 — —
Virginia§ — 0 2 17 11 1 5 15 122 122 20 10 26 368 368
West Virginia — 0 2 2 5 1 0 7 27 22 2 2 6 52 81
E.S. Central — 1 4 25 23 8 14 25 483 605 1 3 7 118 104
Alabama§ — 0 2 4 6 1 4 9 142 237 1 0 4 36 —
Kentucky — 0 2 11 4 3 4 13 158 179 — 0 4 13 35
Mississippi — 0 1 3 3 — 1 6 42 49 — 0 3 9 3
Tennessee§ — 0 2 7 10 4 3 10 141 140 — 1 4 60 66
W.S. Central 1 1 9 58 59 28 56 753 1,818 2,116 — 1 40 58 569
Arkansas§ — 0 2 5 5 5 4 29 106 250 — 0 10 20 28
Louisiana — 0 4 12 11 — 1 4 20 123 — 0 0 — —
Oklahoma — 0 7 14 5 2 0 41 28 36 — 0 30 38 21
Texas§ 1 0 7 27 38 21 49 681 1,664 1,707 — 0 30 — 520
Mountain 1 1 6 42 49 11 21 41 705 652 2 1 8 43 72
Arizona — 0 2 11 12 3 6 14 232 155 — 0 5 — —
Colorado — 0 4 13 14 6 3 13 125 175 — 0 0 — —
Idaho§ — 0 1 5 6 2 2 19 112 58 — 0 2 5 3
Montana§ — 0 1 1 5 — 1 8 33 19 1 0 4 10 20
Nevada§ 1 0 1 8 4 — 0 7 18 19 1 0 1 3 4
New Mexico§ — 0 1 3 3 — 1 6 47 45 — 0 3 9 20
Utah — 0 1 1 1 — 4 10 133 160 — 0 2 2 6
Wyoming§ — 0 1 — 4 — 0 1 5 21 — 0 3 14 19
Pacific 1 3 16 108 141 19 34 186 1,763 848 1 3 12 120 176
Alaska — 0 2 1 4 — 0 6 25 32 — 0 2 11 10
California 1 2 13 70 90 — 22 162 1,283 410 1 3 12 99 156
Hawaii — 0 1 1 5 — 0 5 25 28 — 0 0 — —
Oregon — 1 3 24 29 1 5 15 224 190 — 0 2 10 10
Washington — 0 7 12 13 18 4 24 206 188 — 0 0 — —
Territories
American Samoa — 0 0 — — — 0 0 — — N 0 0 N N
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 2 — — — 0 0 — —
Puerto Rico — 0 1 — — — 0 0 — 1 — 1 3 30 28
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Data for meningococcal disease, invasive caused by serogroups A, C, Y, and W-135; serogroup B; other serogroup; and unknown serogroup are available in Table I.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending August 28, 2010, and August 29, 2009 (34th week)*
Reporting area
Salmonellosis Shiga toxin-producing E. coli (STEC)† Shigellosis
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 947 885 1,555 27,621 29,935 74 80 198 2,749 2,946 178 253 528 8,489 10,837
New England 4 29 335 1,427 1,667 — 3 37 134 186 1 5 42 204 256
Connecticut — 0 318 318 430 — 0 37 37 67 — 0 36 36 43
Maine§ 2 2 7 77 91 — 0 2 11 14 1 0 2 5 2
Massachusetts — 21 47 775 786 — 2 8 59 64 — 4 15 147 175
New Hampshire 1 3 10 116 213 — 0 2 17 24 — 0 2 6 14
Rhode Island§ — 2 17 97 95 — 0 26 2 — — 0 7 9 17
Vermont§ 1 1 5 44 52 — 0 2 8 17 — 0 1 1 5
Mid. Atlantic 97 96 202 3,302 3,569 9 8 25 318 279 22 34 66 1,085 2,071
New Jersey — 14 43 391 762 — 1 4 32 74 — 6 17 200 449
New York (Upstate) 63 24 78 907 812 9 3 15 130 85 15 4 19 141 144
New York City 3 25 53 827 817 — 1 4 44 40 1 7 15 196 307
Pennsylvania 31 29 72 1,177 1,178 — 2 13 112 80 6 17 35 548 1,171
E.N. Central 41 82 227 3,208 3,611 8 12 33 440 531 8 25 235 1,125 2,002
Illinois — 26 111 1,119 1,026 — 2 6 68 127 — 9 228 611 456
Indiana — 10 49 298 423 — 1 8 64 70 — 1 5 30 53
Michigan 7 15 41 559 680 1 2 16 109 92 3 4 9 153 163
Ohio 34 24 47 910 998 7 2 11 104 95 5 7 23 223 927
Wisconsin — 9 40 322 484 — 3 8 95 147 — 4 14 108 403
W.N. Central 22 44 94 1,524 1,852 1 10 41 404 517 3 49 88 1,653 640
Iowa 3 7 36 341 298 — 2 15 112 120 1 1 5 38 45
Kansas 11 7 20 278 269 1 1 6 46 45 2 4 14 176 159
Minnesota — 6 32 178 404 — 1 17 31 132 — 0 6 14 52
Missouri — 13 38 462 423 — 3 29 151 93 — 44 75 1,395 358
Nebraska§ 8 4 13 159 268 — 1 6 47 68 — 0 4 25 19
North Dakota — 0 39 25 35 — 0 7 — 4 — 0 5 — 3
South Dakota — 2 6 81 155 — 0 5 17 55 — 0 2 5 4
S. Atlantic 487 265 523 8,018 7,884 20 13 30 440 432 59 40 85 1,473 1,674
Delaware 2 3 9 95 72 — 0 2 4 10 — 2 10 36 72
District of Columbia — 1 4 45 64 — 0 1 5 2 — 0 4 20 17
Florida 193 126 277 3,392 3,328 8 3 14 147 107 28 13 49 642 294
Georgia 93 40 105 1,340 1,474 2 1 15 66 49 15 12 25 445 443
Maryland§ 23 15 45 602 506 3 2 6 55 56 3 3 10 79 299
North Carolina 72 31 144 1,024 1,113 4 1 7 44 74 3 2 17 115 315
South Carolina§ 60 20 74 760 532 — 0 3 15 23 4 1 5 46 88
Virginia§ 40 18 68 636 643 3 2 15 90 93 6 2 15 89 140
West Virginia 4 3 16 124 152 — 0 5 14 18 — 0 2 1 6
E.S. Central 40 49 117 1,739 1,953 1 4 10 153 150 5 12 40 452 581
Alabama§ — 14 40 421 534 — 1 4 31 38 — 3 10 95 108
Kentucky 11 8 29 325 327 — 1 6 34 53 3 4 28 179 140
Mississippi — 12 44 450 576 — 0 2 10 6 — 1 3 27 31
Tennessee§ 29 14 42 543 516 1 2 8 78 53 2 5 11 151 302
W.S. Central 66 107 547 2,851 3,300 3 5 68 155 191 39 46 251 1,427 2,046
Arkansas§ 29 10 36 400 379 — 1 5 36 26 — 1 9 34 235
Louisiana 10 19 44 641 712 1 0 3 8 16 1 3 10 137 143
Oklahoma 27 10 46 355 390 — 0 27 13 19 9 6 96 186 180
Texas§ — 59 477 1,455 1,819 2 3 41 98 130 29 34 144 1,070 1,488
Mountain 35 48 91 1,670 2,069 15 9 27 359 381 9 14 39 453 800
Arizona 1 18 35 523 683 — 1 6 42 47 4 8 25 236 579
Colorado 17 11 23 394 435 12 2 18 140 124 4 2 6 75 62
Idaho§ 5 3 9 103 127 3 1 7 46 54 1 0 3 18 6
Montana§ 2 2 7 66 84 — 1 7 28 26 — 0 1 5 11
Nevada§ 9 4 19 189 181 — 0 5 20 21 — 1 7 21 47
New Mexico§ 1 5 12 169 261 — 1 4 24 26 — 2 9 74 79
Utah — 5 17 196 230 — 1 11 48 74 — 0 4 24 15
Wyoming§ — 1 9 30 68 — 0 2 11 9 — 0 2 — 1
Pacific 155 115 299 3,882 4,030 17 10 46 346 279 32 20 64 617 767
Alaska — 1 5 57 51 — 0 1 1 1 — 0 2 — 1
California 116 84 227 2,908 3,032 6 5 35 151 150 30 16 51 504 602
Hawaii 12 4 62 104 175 — 0 4 14 4 — 0 3 10 29
Oregon 5 8 48 365 305 1 2 11 59 43 — 1 4 36 38
Washington 22 15 61 448 467 10 3 19 121 81 2 2 22 67 97
Territories
American Samoa — 1 1 2 — — 0 0 — — — 0 1 1 3
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 2 4 7 — 0 0 — — — 0 3 1 5
Puerto Rico — 6 39 127 352 — 0 0 — — — 0 1 — 10
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Includes E. coli O157:H7; Shiga toxin-positive, serogroup non-O157; and Shiga toxin-positive, not serogrouped.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending August 28, 2010, and August 29, 2009 (34th week)*











Previous 52 weeks Cum  
2010
Cum  
2009Med Max Med Max
United States 4 2 14 100 116 18 15 421 873 1,021
New England — 0 1 — 2 — 0 1 1 9
Connecticut — 0 0 — — — 0 0 — —
Maine§ — 0 0 — — — 0 1 1 4
Massachusetts — 0 0 — 1 — 0 1 — 5
New Hampshire — 0 0 — — — 0 1 — —
Rhode Island§ — 0 0 — — — 0 0 — —
Vermont§ — 0 1 — 1 — 0 0 — —
Mid. Atlantic — 0 2 13 9 — 1 5 39 73
New Jersey — 0 0 — 2 — 0 3 — 48
New York (Upstate) — 0 1 1 — — 0 3 10 10
New York City — 0 1 1 — — 0 4 19 5
Pennsylvania — 0 2 11 7 — 0 1 10 10
E.N. Central 1 0 1 4 8 — 0 7 52 70
Illinois — 0 1 2 1 — 0 5 19 43
Indiana 1 0 1 2 3 — 0 5 25 8
Michigan — 0 1 — 3 — 0 2 3 1
Ohio — 0 0 — — — 0 2 5 15
Wisconsin — 0 0 — 1 — 0 1 — 3
W.N. Central — 0 2 8 16 1 2 19 173 218
Iowa — 0 0 — 1 — 0 1 2 4
Kansas — 0 1 2 1 — 0 0 — —
Minnesota — 0 1 — 1 — 0 1 — 1
Missouri — 0 1 5 6 — 2 18 166 209
Nebraska§ — 0 1 1 7 1 0 1 4 4
North Dakota — 0 0 — — — 0 1 1 —
South Dakota — 0 0 — — — 0 0 — —
S. Atlantic 3 1 10 53 55 13 5 59 319 310
Delaware — 0 1 1 — — 0 2 14 15
District of Columbia — 0 0 — — — 0 1 — —
Florida — 0 1 2 — 1 0 1 7 4
Georgia — 0 6 33 45 — 0 0 — —
Maryland§ — 0 1 1 2 — 0 4 28 32
North Carolina 2 0 3 11 5 10 1 48 178 200
South Carolina§ 1 0 0 1 3 1 0 2 10 15
Virginia§ — 0 2 4 — 1 1 11 82 43
West Virginia — 0 0 — — — 0 1 — 1
E.S. Central — 0 2 11 7 2 3 28 235 204
Alabama§ — 0 1 2 3 — 1 8 44 46
Kentucky — 0 2 6 1 — 0 0 — —
Mississippi — 0 0 — — — 0 1 2 9
Tennessee§ — 0 2 3 3 2 3 20 189 149
W.S. Central — 0 3 1 6 2 1 408 48 114
Arkansas§ — 0 1 — — — 0 110 20 59
Louisiana — 0 0 — — — 0 1 2 2
Oklahoma — 0 2 — 5 1 0 287 16 39
Texas§ — 0 1 1 1 1 0 11 10 14
Mountain — 0 2 3 12 — 0 3 5 23
Arizona — 0 2 1 6 — 0 2 1 11
Colorado — 0 0 — 1 — 0 0 — —
Idaho§ — 0 0 — — — 0 1 2 1
Montana§ — 0 1 2 4 — 0 1 1 6
Nevada§ — 0 0 — — — 0 0 — 1
New Mexico§ — 0 0 — — — 0 1 1 1
Utah — 0 0 — — — 0 0 — 1
Wyoming§ — 0 0 — 1 — 0 0 — 2
Pacific — 0 2 7 1 — 0 1 1 —
Alaska N 0 0 N N N 0 0 N N
California — 0 2 6 1 — 0 0 — —
Hawaii N 0 0 N N N 0 0 N N
Oregon — 0 1 1 — — 0 1 1 —
Washington — 0 0 — — — 0 0 — —
Territories
American Samoa N 0 0 N N N 0 0 N N
C.N.M.I. — — — — — — — — — —
Guam N 0 0 N N N 0 0 N N
Puerto Rico N 0 0 N N N 0 0 N N
U.S. Virgin Islands — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Illnesses with similar clinical presentation that result from Spotted fever group rickettsia infections are reported as Spotted fever rickettsioses. Rocky Mountain spotted fever (RMSF) caused 
by Rickettsia rickettsii, is the most common and well-known spotted fever.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending August 28, 2010, and August 29, 2009 (34th week)*
Streptococcus pneumoniae,† invasive disease
Reporting area
All ages Age <5 Syphilis, primary and secondary
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 80 187 491 9,864 2,060 17 50 156 1,548 1,569 99 236 413 7,482 9,290
New England — 7 100 564 38 — 1 24 74 50 2 7 22 287 221
Connecticut — 0 93 255 — — 0 22 24 — — 1 10 54 42
Maine§ — 1 6 86 10 — 0 2 7 4 1 0 3 16 2
Massachusetts — 0 5 53 3 — 1 4 35 35 — 5 15 174 155
New Hampshire — 0 7 59 — — 0 2 3 8 — 0 1 13 12
Rhode Island§ — 0 34 53 14 — 0 2 2 1 1 0 4 28 10
Vermont§ — 1 6 58 11 — 0 1 3 2 — 0 2 2 —
Mid. Atlantic 6 12 54 844 125 2 7 48 243 203 33 33 45 1,125 1,183
New Jersey — 1 8 76 — — 1 5 39 33 5 4 12 150 158
New York (Upstate) 2 3 12 114 50 — 3 19 83 91 3 2 11 91 81
New York City 2 4 25 314 7 1 1 24 82 66 19 18 31 647 722
Pennsylvania 2 6 22 340 68 1 0 5 39 13 6 7 16 237 222
E.N. Central 12 31 98 1,991 469 1 8 18 247 261 1 28 46 847 1,007
Illinois — 1 7 66 — — 2 5 59 41 — 12 23 302 493
Indiana — 7 23 408 182 — 1 6 35 53 — 3 13 109 102
Michigan 1 7 27 466 19 — 2 6 56 49 — 3 12 141 154
Ohio 7 14 49 831 268 1 2 6 68 89 1 8 13 268 227
Wisconsin 4 4 22 220 — — 1 4 29 29 — 1 3 27 31
W.N. Central 4 8 182 580 134 1 2 12 104 130 4 5 13 187 210
Iowa — 0 0 — — — 0 0 — — — 0 2 9 16
Kansas 1 1 7 71 46 — 0 2 11 14 — 0 3 11 19
Minnesota — 0 179 287 32 — 0 10 44 58 — 1 9 68 48
Missouri — 2 9 78 47 — 0 3 28 37 4 3 8 94 120
Nebraska§ 1 1 7 91 — 1 0 2 12 9 — 0 1 5 4
North Dakota 2 0 11 39 7 — 0 1 2 4 — 0 1 — 3
South Dakota — 0 3 14 2 — 0 2 7 8 — 0 0 — —
S. Atlantic 19 40 144 2,286 923 8 12 28 391 370 14 57 218 1,796 2,228
Delaware — 0 3 24 15 — 0 2 — — — 0 2 4 22
District of Columbia — 0 4 21 17 — 0 2 7 3 — 2 8 89 123
Florida 7 18 89 1,055 541 3 3 18 145 134 1 19 32 635 701
Georgia 4 10 28 371 262 2 4 12 105 91 — 11 167 348 517
Maryland§ 3 5 25 327 4 2 1 6 39 58 — 6 11 190 187
North Carolina — 0 0 — — — 0 0 — — 9 8 31 247 372
South Carolina§ 3 5 25 358 — 1 1 4 40 33 1 2 7 93 85
Virginia§ — 0 4 41 — — 1 4 39 33 3 4 22 187 217
West Virginia 2 1 21 89 84 — 0 4 16 18 — 0 2 3 4
E.S. Central 6 16 50 869 201 — 2 8 84 94 6 18 39 563 772
Alabama§ — 0 0 — — — 0 0 — — — 5 12 152 303
Kentucky 1 2 16 131 55 — 0 2 10 7 3 2 13 86 43
Mississippi — 1 6 40 34 — 0 2 9 17 — 4 17 122 144
Tennessee§ 5 12 44 698 112 — 2 7 65 70 3 6 17 203 282
W.S. Central 24 17 90 1,260 84 4 6 41 202 233 18 35 71 1,032 1,895
Arkansas§ — 2 9 118 40 — 0 3 11 32 1 4 14 107 150
Louisiana — 1 8 56 44 — 0 3 17 17 — 4 23 64 551
Oklahoma 1 0 5 35 — 1 1 5 35 39 — 2 6 52 61
Texas§ 23 11 82 1,051 — 3 3 34 139 145 17 26 42 809 1,133
Mountain 9 19 82 1,259 84 1 5 12 175 206 5 9 20 289 349
Arizona 2 7 51 584 — — 2 7 77 92 — 3 7 92 166
Colorado 6 6 20 372 — 1 1 4 48 30 1 2 5 76 62
Idaho§ — 0 2 11 — — 0 2 5 7 — 0 1 2 3
Montana§ — 0 2 13 — — 0 1 1 — — 0 1 1 —
Nevada§ — 1 4 54 34 — 0 1 5 7 4 1 10 70 62
New Mexico§ 1 2 9 114 — — 0 4 14 24 — 1 4 28 34
Utah — 2 9 102 41 — 1 4 22 45 — 0 4 20 19
Wyoming§ — 0 1 9 9 — 0 1 3 1 — 0 0 — 3
Pacific — 4 14 211 2 — 0 7 28 22 16 40 64 1,356 1,425
Alaska — 1 9 80 — — 0 5 18 14 — 0 1 1 —
California — 2 12 131 — — 0 2 10 — 14 36 59 1,193 1,261
Hawaii — 0 1 — 2 — 0 1 — 8 — 0 3 24 24
Oregon — 0 0 — — — 0 0 — — — 0 5 6 40
Washington — 0 0 — — — 0 0 — — 2 3 10 132 100
Territories
American Samoa — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 0 — — — 0 0 — — — 0 0 — —
Puerto Rico — 0 0 — — — 0 0 — — — 4 17 144 144
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional.
† Includes drug resistant and susceptible cases of invasive Streptococcus pneumoniae disease among children <5 years and among all ages. Case definition: Isolation of S. pneumoniae from 
a normally sterile body site (e.g., blood or cerebrospinal fluid).
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
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TABLE II. (Continued) Provisional cases of selected notifiable diseases, United States, weeks ending August 28, 2010, and August 29, 2009 (34th week)*
West Nile virus disease†
Reporting area
Varicella (chickenpox)§ Neuroinvasive Nonneuroinvasive¶
Current 
week












Previous 52 weeks Cum 
2010
Cum 
2009Med Max Med Max Med Max
United States 87 325 546 9,434 14,698 — 0 45 96 255 — 1 30 81 244
New England 1 15 36 457 726 — 0 1 1 — — 0 0 — —
Connecticut — 6 20 212 348 — 0 0 — — — 0 0 — —
Maine§ — 3 15 130 130 — 0 0 — — — 0 0 — —
Massachusetts — 0 1 — 3 — 0 1 1 — — 0 0 — —
New Hampshire 1 2 8 85 145 — 0 0 — — — 0 0 — —
Rhode Island§ — 1 12 18 24 — 0 0 — — — 0 0 — —
Vermont§ — 0 10 12 76 — 0 0 — — — 0 0 — —
Mid. Atlantic 11 33 66 1,072 1,432 — 0 6 17 3 — 0 2 5 1
New Jersey — 9 30 392 299 — 0 2 3 2 — 0 0 — —
New York (Upstate) N 0 0 N N — 0 4 9 1 — 0 2 5 1
New York City — 0 0 — — — 0 2 4 — — 0 0 — —
Pennsylvania 11 22 52 680 1,133 — 0 1 1 — — 0 0 — —
E.N. Central 13 108 176 3,200 4,581 — 0 4 4 8 — 0 1 1 4
Illinois 2 26 49 822 1,093 — 0 3 — 5 — 0 0 — —
Indiana§ 1 6 35 298 340 — 0 1 — 2 — 0 0 — 2
Michigan 1 35 62 976 1,323 — 0 2 3 — — 0 1 1 —
Ohio 8 28 56 887 1,413 — 0 1 1 — — 0 0 — 2
Wisconsin 1 7 24 217 412 — 0 0 — 1 — 0 0 — —
W.N. Central — 13 40 360 967 — 0 5 7 20 — 0 8 24 51
Iowa N 0 0 N N — 0 0 — — — 0 1 1 4
Kansas§ — 4 18 96 411 — 0 1 — 3 — 0 1 2 7
Minnesota — 0 0 — — — 0 1 2 1 — 0 1 — 1
Missouri — 6 16 215 461 — 0 2 2 3 — 0 1 — —
Nebraska§ N 0 0 N N — 0 1 3 7 — 0 6 8 28
North Dakota — 0 26 28 57 — 0 0 — — — 0 1 4 1
South Dakota — 0 7 21 38 — 0 1 — 6 — 0 2 9 10
S. Atlantic 23 37 99 1,459 1,844 — 0 4 6 11 — 0 2 3 —
Delaware§ — 0 4 11 10 — 0 0 — — — 0 0 — —
District of Columbia — 0 4 15 24 — 0 0 — 2 — 0 0 — —
Florida§ 8 15 57 729 916 — 0 2 2 1 — 0 1 — —
Georgia N 0 0 N N — 0 1 1 2 — 0 1 3 —
Maryland§ N 0 0 N N — 0 1 3 — — 0 1 — —
North Carolina N 0 0 N N — 0 0 — — — 0 0 — —
South Carolina§ — 0 35 75 93 — 0 2 — 3 — 0 0 — —
Virginia§ 7 11 34 333 499 — 0 1 — 3 — 0 0 — —
West Virginia 8 8 26 296 302 — 0 0 — — — 0 0 — —
E.S. Central 5 6 28 196 386 — 0 5 1 25 — 0 3 4 19
Alabama§ 5 6 27 189 383 — 0 0 — — — 0 1 1 —
Kentucky N 0 0 N N — 0 1 — 2 — 0 0 — —
Mississippi — 0 2 7 3 — 0 3 1 21 — 0 2 3 16
Tennessee§ N 0 0 N N — 0 2 — 2 — 0 1 — 3
W.S. Central 24 58 285 1,943 3,705 — 0 12 9 83 — 0 6 3 27
Arkansas§ — 3 32 122 373 — 0 1 1 6 — 0 0 — —
Louisiana — 1 8 40 99 — 0 2 5 9 — 0 2 2 9
Oklahoma N 0 0 N N — 0 2 — 4 — 0 0 — 2
Texas§ 24 49 272 1,781 3,233 — 0 12 3 64 — 0 4 1 16
Mountain 10 22 37 713 972 — 0 12 36 56 — 0 13 29 91
Arizona — 0 0 — — — 0 8 35 11 — 0 8 19 5
Colorado§ 8 8 20 283 365 — 0 7 1 23 — 0 7 9 51
Idaho§ N 0 0 N N — 0 2 — 7 — 0 4 — 19
Montana§ — 3 17 153 119 — 0 0 — 2 — 0 1 — 2
Nevada§ N 0 0 N N — 0 0 — 7 — 0 0 — 5
New Mexico§ 2 1 7 72 95 — 0 2 — 4 — 0 1 — 2
Utah — 6 22 192 393 — 0 1 — — — 0 0 — 1
Wyoming§ — 0 3 13 — — 0 1 — 2 — 0 2 1 6
Pacific — 1 5 34 85 — 0 12 15 49 — 0 4 12 51
Alaska — 0 5 28 51 — 0 0 — — — 0 0 — —
California — 0 0 — — — 0 8 15 33 — 0 4 12 30
Hawaii — 0 2 6 34 — 0 0 — — — 0 0 — —
Oregon N 0 0 N N — 0 1 — — — 0 1 — 9
Washington N 0 0 N N — 0 6 — 16 — 0 1 — 12
Territories
American Samoa N 0 0 N N — 0 0 — — — 0 0 — —
C.N.M.I. — — — — — — — — — — — — — — —
Guam — 0 3 12 15 — 0 0 — — — 0 0 — —
Puerto Rico — 5 30 180 390 — 0 0 — — — 0 0 — —
U.S. Virgin Islands — 0 0 — — — 0 0 — — — 0 0 — —
C.N.M.I.: Commonwealth of Northern Mariana Islands.
U: Unavailable.   —: No reported cases.   N: Not reportable.   NN: Not Nationally Notifiable.   Cum: Cumulative year-to-date counts.   Med: Median.   Max: Maximum.
* Incidence data for reporting years 2009 and 2010 are provisional. Data for HIV/AIDS, AIDS, and TB, when available, are displayed in Table IV, which appears quarterly.
† Updated weekly from reports to the Division of Vector-Borne Infectious Diseases, National Center for Zoonotic, Vector-Borne, and Enteric Diseases (ArboNET Surveillance). Data for California 
serogroup, eastern equine, Powassan, St. Louis, and western equine diseases are available in Table I.
§ Contains data reported through the National Electronic Disease Surveillance System (NEDSS).
¶ Not reportable in all states. Data from states where the condition is not reportable are excluded from this table, except starting in 2007 for the domestic arboviral diseases and influenza-
associated pediatric mortality, and in 2003 for SARS-CoV. Reporting exceptions are available at http://www.cdc.gov/ncphi/disss/nndss/phs/infdis.htm.
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TABLE III. Deaths in 122 U.S. cities,* week ending August 28, 2010 (34th week)
Reporting area
All causes, by age (years)
P&I† 
Total Reporting area




Ages ≥65 45–64 25–44 1–24 <1
All  
Ages ≥65 45–64 25–44 1–24 <1
New England 496 332 110 32 14 8 41 S. Atlantic 1,141 718 279 85 35 24 73
Boston, MA 142 90 32 10 4 6 13 Atlanta, GA 145 84 42 14 2 3 12
Bridgeport, CT 26 19 6 — 1 — 1 Baltimore, MD 167 91 54 12 6 4 4
Cambridge, MA 15 10 2 2 1 — 3 Charlotte, NC 112 77 21 6 7 1 5
Fall River, MA 21 15 5 1 — — 3 Jacksonville, FL 145 102 30 8 3 2 21
Hartford, CT 55 42 10 2 1 — 4 Miami, FL 90 59 17 9 2 3 8
Lowell, MA 25 18 6 1 — — 3 Norfolk, VA 44 30 8 4 1 1 3
Lynn, MA 7 3 1 3 — — — Richmond, VA 54 31 13 4 4 2 2
New Bedford, MA 23 18 4 — 1 — — Savannah, GA 54 35 14 — 2 3 3
New Haven, CT 38 20 13 4 1 — 5 St. Petersburg, FL 47 26 14 2 3 2 2
Providence, RI 59 41 13 2 2 1 3 Tampa, FL 195 135 43 12 3 2 6
Somerville, MA 2 2 — — — — — Washington, D.C. 82 46 19 14 2 1 5
Springfield, MA 21 13 5 1 1 1 2 Wilmington, DE 6 2 4 — — — 2
Waterbury, CT 14 10 3 1 — — — E.S. Central 956 619 239 63 15 20 58
Worcester, MA 48 31 10 5 2 — 4 Birmingham, AL 177 119 44 7 1 6 11
Mid. Atlantic 1,865 1,296 390 104 32 39 82 Chattanooga, TN 99 69 20 7 2 1 6
Albany, NY 51 38 9 — 1 3 2 Knoxville, TN 110 81 22 6 — 1 8
Allentown, PA 22 20 — 1 — 1 1 Lexington, KY 65 37 22 4 1 1 —
Buffalo, NY 60 42 15 1 — 2 — Memphis, TN 163 100 44 10 3 6 16
Camden, NJ 12 9 1 — — 2 — Mobile, AL 151 97 39 12 2 1 5
Elizabeth, NJ 11 8 2 — 1 — — Montgomery, AL 48 32 8 6 2 — 3
Erie, PA 51 39 7 5 — — 3 Nashville, TN 143 84 40 11 4 4 9
Jersey City, NJ 23 18 5 — — — — W.S. Central 1,326 834 334 82 46 29 75
New York City, NY 906 646 180 53 15 9 45 Austin, TX 94 61 21 9 1 2 5
Newark, NJ 24 11 6 4 2 1 1 Baton Rouge, LA 79 38 17 14 10 — 2
Paterson, NJ 10 4 3 3 — — — Corpus Christi, TX 55 32 13 4 2 4 2
Philadelphia, PA 402 239 117 27 7 12 13 Dallas, TX 197 116 54 13 10 4 13
Pittsburgh, PA§ 31 23 6 — — 2 1 El Paso, TX 86 64 17 4 — 1 3
Reading, PA 31 24 3 1 1 1 3 Fort Worth, TX U U U U U U U
Rochester, NY 66 48 7 5 2 4 2 Houston, TX 350 215 101 14 10 9 24
Schenectady, NY 12 9 2 1 — — — Little Rock, AR 55 37 14 1 2 1 1
Scranton, PA 24 18 5 — 1 — — New Orleans, LA U U U U U U U
Syracuse, NY 75 57 12 2 2 2 8 San Antonio, TX 224 149 48 18 6 3 11
Trenton, NJ 28 22 6 — — — 1 Shreveport, LA 73 44 21 1 3 4 4
Utica, NY 9 7 1 1 — — — Tulsa, OK 113 78 28 4 2 1 10
Yonkers, NY 17 14 3 — — — 2 Mountain 965 624 234 73 18 16 56
E.N. Central 1,863 1,267 419 110 31 36 105 Albuquerque, NM 115 79 23 7 3 3 7
Akron, OH 53 37 11 3 1 1 7 Boise, ID 51 35 13 2 1 — 4
Canton, OH 33 24 6 1 — 2 4 Colorado Springs, CO 52 29 18 4 1 — —
Chicago, IL 259 165 62 21 8 3 17 Denver, CO 87 53 20 9 1 4 8
Cincinnati, OH 89 57 21 6 1 4 6 Las Vegas, NV 303 210 70 20 1 2 17
Cleveland, OH 251 179 51 12 5 4 8 Ogden, UT 30 23 5 2 — — 2
Columbus, OH 255 165 62 20 2 6 10 Phoenix, AZ 165 89 46 18 6 6 10
Dayton, OH 104 77 21 3 3 — 6 Pueblo, CO 30 21 7 1 1 — 2
Detroit, MI 125 62 46 8 1 8 3 Salt Lake City, UT 121 80 30 8 2 1 6
Evansville, IN 37 31 5 1 — — 7 Tucson, AZ 11 5 2 2 2 — —
Fort Wayne, IN 56 38 13 2 1 2 4 Pacific 1,566 1,049 352 92 41 31 124
Gary, IN 12 6 3 3 — — — Berkeley, CA 6 3 3 — — — —
Grand Rapids, MI 49 29 13 5 2 — 1 Fresno, CA 119 80 22 9 3 5 7
Indianapolis, IN 149 98 36 7 4 4 11 Glendale, CA 27 20 6 1 — — 5
Lansing, MI 38 28 7 3 — — 2 Honolulu, HI 66 44 15 4 1 2 5
Milwaukee, WI 57 41 10 6 — — 4 Long Beach, CA 51 36 8 4 1 2 5
Peoria, IL 34 25 6 2 1 — 5 Los Angeles, CA 240 153 54 20 10 3 32
Rockford, IL 47 40 6 — — 1 6 Pasadena, CA 23 16 6 1 — — 1
South Bend, IN 53 38 12 2 — 1 — Portland, OR 93 66 18 5 4 — 6
Toledo, OH 108 83 21 3 1 — 3 Sacramento, CA 188 121 51 10 5 1 17
Youngstown, OH 54 44 7 2 1 — 1 San Diego, CA 146 94 36 7 3 5 11
W.N. Central 542 340 138 34 18 12 26 San Francisco, CA 102 74 20 5 2 1 9
Des Moines, IA 76 51 16 3 1 5 4 San Jose, CA 190 137 42 7 2 2 12
Duluth, MN 31 26 5 — — — — Santa Cruz, CA 20 17 3 — — — 3
Kansas City, KS U U U U U U U Seattle, WA 136 81 35 8 5 7 5
Kansas City, MO 103 67 21 6 4 5 8 Spokane, WA 63 43 14 2 1 3 4
Lincoln, NE 31 28 2 1 — — 1 Tacoma, WA 96 64 19 9 4 — 2
Minneapolis, MN 52 29 18 3 1 1 3 Total¶ 10,720 7,079 2,495 675 250 215 640
Omaha, NE 89 57 25 4 3 — 5
St. Louis, MO 101 47 35 14 5 — 4
St. Paul, MN 59 35 16 3 4 1 1
Wichita, KS U U U U U U U
U: Unavailable.   —: No reported cases.   
* Mortality data in this table are voluntarily reported from 122 cities in the United States, most of which have populations of >100,000. A death is reported by the place of its occurrence and 
by the week that the death certificate was filed. Fetal deaths are not included.
† Pneumonia and influenza.
§ Because of changes in reporting methods in this Pennsylvania city, these numbers are partial counts for the current week. Complete counts will be available in 4 to 6 weeks.
¶ Total includes unknown ages.
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